{"numRecords":"445","DataElementQueryResults":[{"publicId":"6004346","version":"1","preferredName":"Disease or Disorder Pathology Result Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A response to questions which are necessary to allow a person to participate in a clinical study that are related to the outcome of pathologic examination(s) of disease(s) as outlined in the protocol.","longName":"DZDR_PATH_RESLT_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BAA3D27-7EB1-35E8-E053-F662850A3DAC","latestVersionIndicator":"Yes","beginDate":"2017-10-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-16","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"10/16/17 tt CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6004361","version":"1","preferredName":"Treating Site Therapeutic Equipment Ability Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow a person to participate in a clinical study that are related to the ability of a healthcare facility to perform therapeutic activities as outlined in the protocol.","longName":"TXST_THER_EQPT_ABLY_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BAABF56-7253-1A59-E053-F662850A963A","latestVersionIndicator":"Yes","beginDate":"2017-10-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-16","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"10/16/17 tt CE7,","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6004378","version":"1","preferredName":"Neurocognitive Assessment Consent Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow a person to participate in a clinical study that are related to the patient's consent of neurological assessments, as outlined in the protocol.","longName":"NEURO_ASSESS_CNST_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BAC8630-58CF-18E9-E053-F662850ACDCA","latestVersionIndicator":"Yes","beginDate":"2017-10-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-16","modifiedBy":"CLOHNES","dateModified":"2023-10-11","changeNote":"10/16/17 tt CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6004911","version":"1","preferredName":"Patient Refuse Contraception Eligibility Determination Indicator","preferredDefinition":"The response regarding a patient's refusal to use contraception and its affect on the patient being eligible to participate in a clinical trial.","longName":"PT_REF_CON_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BAEEF20-BD02-4402-E053-F662850A8F4E","latestVersionIndicator":"Yes","beginDate":"2017-10-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-17","modifiedBy":"RODGERSC","dateModified":"2018-10-05","changeNote":"10/5/18 Released for reuse/tt. 10/17/17 tt CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6004930","version":"1","preferredName":"Imaging Procedure Unable To Do Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow clinical trial participation regarding the person's inability to undergo any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy, as outlined in the study protocol.","longName":"IMAG_PROC_UNABL_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BBF8EAA-AA1A-4E0D-E053-F662850A2BF5","latestVersionIndicator":"Yes","beginDate":"2017-10-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-17","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"10/17/17 tt CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6005096","version":"1","preferredName":"Quality of Life Questionnaire Completion Assessment Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions related to the completion of QOL questionnaires, as outlined in the protocol, which are necessary to allow a person to participate in a clinical study.","longName":"QOL_QSTNR_COMP_ASSESS_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BC15DD9-8AE7-52C8-E053-F662850A0B62","latestVersionIndicator":"Yes","beginDate":"2017-10-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-17","modifiedBy":"CLOHNES","dateModified":"2023-03-01","changeNote":"10/17/17 tt CE7.","administrativeNotes":"12/20/22 added alt OID, CCTG and AQT for ticket number CADSR0001818 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6005106","version":"1","preferredName":"Informed Consent Responsible Person Discussion Date","preferredDefinition":"The date of informed consent discussion by a person worthy of responsibility, trust, or held accountable.","longName":"ICF_RSPBL_PRSN_DSCN_DT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BC2CEE8-6C5A-46DD-E053-F662850AE1F8","latestVersionIndicator":"Yes","beginDate":"2017-10-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-17","modifiedBy":"WINCHC","dateModified":"2022-02-02","changeNote":"11-21-18 TT released/CWinch. 10/17/17 tt CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6005108","version":"1","preferredName":"Baseline QOL Complete Form Indicator","preferredDefinition":"The indicator as to whether the patient completed the baseline quality of life form.","longName":"BSL_QOL_COMP_FOR_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BC3B4F6-EE6D-49F0-E053-F662850A5323","latestVersionIndicator":"Yes","beginDate":"2017-10-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-17","modifiedBy":"KUMMEROA","dateModified":"2022-05-18","changeNote":"10/17/17 tt CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6009282","version":"1","preferredName":"Quality of Life Questionnaire Completion Exemption Reason","preferredDefinition":"The reason why a person is exempt from completing QOL questionnaires.","longName":"QOL_COMP_EXMP_RSN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C3807D2-C33E-0682-E053-F662850A0AE7","latestVersionIndicator":"Yes","beginDate":"2017-10-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-23","modifiedBy":"KUMMEROA","dateModified":"2023-11-22","changeNote":"11-21-18 TT released/CWinch. 10/23/17 tt CE7.","administrativeNotes":"2023.11.22 AQT added per ticket request CADSR0003107. ak 11/16/23 Alt OID added for CCTG ticket number CADSR0003085 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6009412","version":"1","preferredName":"Exemption Reason Other Specify","preferredDefinition":"Text to describe the reason for exemption different than the one(s) previously specified or mentioned.","longName":"EXEM_RSN_OTH_SPEC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C3B5972-192B-06EE-E053-F662850AF441","latestVersionIndicator":"Yes","beginDate":"2017-10-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-23","modifiedBy":"KUMMEROA","dateModified":"2023-11-22","changeNote":"11-21-18 TT released/CWinch. 10/23/17 tt CE7.","administrativeNotes":"2023.11.22 AQT added per ticket request CADSR0003107. ak 11/16/23 Added alt OID for CCTG ticket number CADSR0003085 cjl; 11/7/23 Added AQT and alt OID for CCTG for ticket number CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6010037","version":"1","preferredName":"Imaging Procedure Performed Result Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow clinical study participation, that are related to the results of any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy, performed according to the study protocol.","longName":"IMAG_PERF_RSLT_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C3DEED8-6D5F-7880-E053-F662850AC78E","latestVersionIndicator":"Yes","beginDate":"2017-10-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-24","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"10/24/17 tt CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6011302","version":"1","preferredName":"Consent Form Language Type","preferredDefinition":"The type of consent form language.","longName":"CONS_FRM_LANG_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C75311F-DF0F-3A89-E053-F662850A9A4B","latestVersionIndicator":"Yes","beginDate":"2017-10-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-26","modifiedBy":"WINCHC","dateModified":"2022-02-02","changeNote":"11-21-18 TT released/CWinch. 10/26/17 tt CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6014203","version":"1","preferredName":"Person Breast Intervention or Procedure Outcome Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response that can have a value of yes, no, or not applicable for questions addressing the results of breast interventional activities that produce an effect, or intended to alter the course of disease that can have preventive, therapeutic, or palliative effects as outlined in the study protocol to allow a person to participate in the clinical trial.","longName":"BRST_INTPROC_OUTCM_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D00343C-9106-21AB-E053-F662850A7CAB","latestVersionIndicator":"Yes","beginDate":"2017-11-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-02","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"11/2/17 TT MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6014207","version":"1","preferredName":"Intervention or Procedure BCS SLNB One or More Positive Axillary Nodes Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response that can have a value of yes, no, or not applicable for questions addressing the presence of one or more lymph nodes in the area of the armpit in which cancerous cells have been detected after treatment or action taken to prevent or treat disease by breast conservation surgery and the surgical removal and examination of the sentinel node, as outlined in the study protocol to allow a person to participate in the clinical trial.","longName":"BCS_SLNB_ONE_MORE_POS_AXN_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D0111D9-1D62-3928-E053-F662850AE59F","latestVersionIndicator":"Yes","beginDate":"2017-11-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-02","modifiedBy":"WINCHC","dateModified":"2020-12-11","changeNote":"11-21-18 TT released/CWinch. 11/2/17 tt  MA39","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6014212","version":"1","preferredName":"Intervention or Procedure Mastectomy SLNB Positive Axillary Lymph Node Count Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response that can have a value of yes, no, or not applicable for questions addressing the number of lymph nodes in the area of the armpit in which cancerous cells have been detected after treatment or action taken to prevent or treat disease by mastectomy and the surgical removal and examination of the sentinel node, as outlined in the study protocol to allow a person to participate in the clinical trial.","longName":"MAST_SLNB_POS_AXN_CNT_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D01A8EC-DDC0-60F3-E053-F662850ACA70","latestVersionIndicator":"Yes","beginDate":"2017-11-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-02","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 11/2/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6014226","version":"1","preferredName":"Intervention or Procedure One or More Positive Axillary Nodes Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response that can have a value of yes, no, or not applicable for questions addressing the presence of one or more lymph nodes in the area of the armpit in which cancerous cells have been detected after treatment or action taken to prevent or treat disease, as outlined in the study protocol to allow a person to participate in the clinical trial.","longName":"INTPROC_ONE_MORE_POS_AXN_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D0227C2-7C3A-5887-E053-F662850AE8EC","latestVersionIndicator":"Yes","beginDate":"2017-11-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-02","modifiedBy":"WINCHC","dateModified":"2020-12-11","changeNote":"11-21-18 TT released/CWinch. 11/2/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6018130","version":"2","preferredName":"Screening Informed Consent Language Type","preferredDefinition":"A description of the screening informed consent language type.","longName":"6018111v1.0:6011119v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC855281-F5BC-4772-E053-731AD00AAB86","latestVersionIndicator":"Yes","beginDate":"2017-11-02","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-05-25","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeNote":"11-21-18 TT released/CWinch. 11/2/17 tt MA39.","administrativeNotes":"5/25/23 Created version 2.0 of CDE to remove dup in long name, added human readable def due to cleanup activities for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6018180","version":"1","preferredName":"Screening Informed Consent Version Date","preferredDefinition":"The version date of the screening consent form.","longName":"SCRN_CONS_FRM_VER_DT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D0596CA-C839-4E49-E053-F662850A5774","latestVersionIndicator":"Yes","beginDate":"2017-11-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-02","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 11/2/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6019303","version":"1","preferredName":"Screening Consent Form Patient Responsible Person Signed Name","preferredDefinition":"Name of the person responsible for screening informed consent.","longName":"SCRN_CONS_RSBL_PRSN_DSCN_NAME","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D05CD05-5905-4275-E053-F662850A6FAC","latestVersionIndicator":"Yes","beginDate":"2017-11-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-02","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 11/2/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6019310","version":"1","preferredName":"Screening Informed Consent Responsible Person Discussion Date","preferredDefinition":"The date of screening consent form discussion by a person worthy of responsibility, trust, or held accountable.","longName":"SCRN_ICF_RSBL_PRSN_DSCN_DT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D05E47E-3BAA-74CA-E053-F662850A7BAE","latestVersionIndicator":"Yes","beginDate":"2017-11-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-02","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 11/2/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6020358","version":"1","preferredName":"Disease or Disorder Nodal Assessment Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow clinical study participation, as outlined in the protocol, that are related to the significance or extent of nodal disease.","longName":"DZDR_NODL_ASSESS_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D060BA3-8D67-6F14-E053-F662850A9646","latestVersionIndicator":"Yes","beginDate":"2017-11-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-02","modifiedBy":"CLOHNES","dateModified":"2023-09-27","changeNote":"11-21-18 TT released/CWinch. 11/2/17 tt MA39.","administrativeNotes":"9/27/23 Added AQT and alt OID, CCTG per ticket request CADSR0002884 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6021132","version":"1","preferredName":"Breast Carcinoma Laboratory Test Result Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions related to the outcome of laboratory tests for breast cancer which are necessary to allow clinical study participation as outlined in the study protocol.","longName":"BRST_CA_LAB_RSLT_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D0808E1-3486-6C70-E053-F662850AAB42","latestVersionIndicator":"Yes","beginDate":"2017-11-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-02","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 11/2/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6021266","version":"1","preferredName":"Screening Informed Consent Intervention or Procedure Outcome Obtain Ind","preferredDefinition":"A response that can have a value of yes, no, or not applicable for questions related to the results of interventions/procedures when a person has agreed to the information addressed in the screening informed consent.","longName":"SCRN_ICF_INTPR_OUTCM_OBTN_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D14CC86-7F7D-2FF8-E053-F662850A0750","latestVersionIndicator":"Yes","beginDate":"2017-11-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-03","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 11/3/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6021672","version":"1","preferredName":"Intervention or Procedure Clinical Trial Eligibility Assessment Criteria Ind","preferredDefinition":"A response to questions which are necessary to allow a patient to participate in a clinical study that are related to assessments of any activities that produces an effect, or that is intended to alter the course of a disease, as outlined in the clinical trial protocol.","longName":"INTPROC_ASSESS_ELIG_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D17AA4E-B707-121E-E053-F662850A0E84","latestVersionIndicator":"Yes","beginDate":"2017-11-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-03","modifiedBy":"TYRRELLM","dateModified":"2023-11-09","changeNote":"11-21-18 TT released/CWinch. 11/3/17 tt MA39.","administrativeNotes":"11.09.2023 Added AQT per request ticket CADSR0003062_mmt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6021673","version":"1","preferredName":"Patient Radiation Therapy Adjuvant Chemotherapy Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions which are necessary to allow clinical study participation that are related to radiation therapy and adjuvant chemotherapy as outlined in the protocol.","longName":"RTX_ADJ_ELIG_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D17FAEB-5BE2-38B2-E053-F662850AE21A","latestVersionIndicator":"Yes","beginDate":"2017-11-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-03","modifiedBy":"WINCHC","dateModified":"2020-12-11","changeNote":"11-21-18 TT released/CWinch. 11/3/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6021908","version":"1","preferredName":"Patient Questionnaires Completion Baseline Future Agreement Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions which are necessary to allow clinical study participation that address the completion of patient questionnaires at baseline, in addition to the patient's act of agreeing to complete future questionnaires as outlined in the protocol.","longName":"QSTR_COMP_BSL_FUTR_AGR_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D197DD5-5109-46A2-E053-F662850A818D","latestVersionIndicator":"Yes","beginDate":"2017-11-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-03","modifiedBy":"CLOHNES","dateModified":"2023-03-01","changeNote":"11-21-18 TT released/CWinch. 11/3/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6024246","version":"1","preferredName":"Patient Specimen Consent And Investigator Confirmation Agreement Ind","preferredDefinition":"A response to questions related to patient specimen consent in addition to the investigator's confirmation of agreeing to the protocol plan for specimens and their arrangements.","longName":"PT_SPEC_CONS_INVR_CONF_AGR_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D51C5B4-B474-0C68-E053-F662850A7CD9","latestVersionIndicator":"Yes","beginDate":"2017-11-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-06","modifiedBy":"CLOHNES","dateModified":"2023-10-13","changeNote":"11-21-18 TT released/CWinch. 11/6/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6024495","version":"1","preferredName":"Informed Consent Optional Biospecimen Storage Signature Date","preferredDefinition":"The date when a person signed the optional consent for biospecimen storage.","longName":"ICF_OPT_BSPEC_STOR_SIG_DT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D54FB97-5534-405A-E053-F662850A970C","latestVersionIndicator":"Yes","beginDate":"2017-11-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-06","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 11/6/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6024681","version":"1","preferredName":"Informed Consent Optional Biospecimen Storage Version Date","preferredDefinition":"The version date of the optional biospecimen consent form.","longName":"ICF_OPT_BSPEC_STOR_VER_DT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D568C91-697E-11A7-E053-F662850A1415","latestVersionIndicator":"Yes","beginDate":"2017-11-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-06","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 11/6/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6025278","version":"1","preferredName":"Informed Consent Optional Biospecimen Storage Negation Complete Reason","preferredDefinition":"The reason a patient did not sign and date the optional consent for biospecimen storage.","longName":"ICF_OPT_BSPEC_STOR_NEG_CMP_RSN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D695C1B-D933-0961-E053-F662850AE5EF","latestVersionIndicator":"Yes","beginDate":"2017-11-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-07","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"11/7/17 tt MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035092","version":"1","preferredName":"Biospecimen Submission Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions which are necessary to allow clinical trial participation that are related to the submission of patient's biospecimens as outlined in the study protocol.","longName":"BSPEC_SUBM_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F33EFA9-B43F-7201-E053-F662850A8D50","latestVersionIndicator":"Yes","beginDate":"2017-11-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-30","modifiedBy":"CLOHNES","dateModified":"2023-10-13","changeNote":"11-21-18 TT released/CWinch. 11/30/17 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035120","version":"1","preferredName":"Patient Optional Cancer Biobank Consent Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions which are necessary to allow clinical trial participation as to whether the patient gives permission to provide specimen(s) for storage in a biobank as outlined in the study protocol.","longName":"OPTN_CA_BIOBNK_CONST_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F47F531-841D-07B5-E053-F662850AAA6B","latestVersionIndicator":"Yes","beginDate":"2017-12-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-01","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 12/1/17 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035128","version":"1","preferredName":"Laboratory Procedure Oncotype DX Breast Cancer Assay Stratification Score","preferredDefinition":"Numeric range of the Oncotype DX Breast Cancer Assay for classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","longName":"LAB_ONCODX_STRAT_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F48BDFE-B8A0-5285-E053-F662850ADFC8","latestVersionIndicator":"Yes","beginDate":"2017-12-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-01","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"12/1/17 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035766","version":"2","preferredName":"Disease-specific Graded Prognostic Assessment Median Overall Survival Result","preferredDefinition":"The outcome of DS-GPA.","longName":"DSGPA_MOS_RSLT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB48DE06-8CDA-33FF-E053-731AD00A83B6","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-05-09","modifiedBy":"CLOHNES","dateModified":"2023-05-09","changeNote":"12/4/17 tt/CE7.","administrativeNotes":"5/9/23 Created this 2.0 version because VD had  minor version 1.1 to change min and max length to fit PVs for CCTG cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6035798","version":"1","preferredName":"Brain Metastases Intervention Or Planned Occurrence Timepoint Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions, which are necessary to allow clinical trial participation, related to the timepoint of interventions or plans for brain metastases as outlined in the study protocol.","longName":"BRAIN_MET_INTVN_PLAN_TMPT_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F86FD93-FECD-7D10-E053-F662850A95CD","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-04","modifiedBy":"CARTERS","dateModified":"2022-04-13","changeNote":"12/4/17 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036135","version":"1","preferredName":"Graded Prognostic Assessment Index Score","preferredDefinition":"A numeric value for the GPA Score.","longName":"GPA_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F87F419-38E8-37E6-E053-F662850A0F0A","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-04","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"12/4/17 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036536","version":"1","preferredName":"Median Survival Time Months Estimated Decimal Place Count","preferredDefinition":"The estimated number of months from either diagnosis or treatment at which half of the patients with a given disease are found to be, or expected to be, still alive.","longName":"MST_MONS_EST_DECPL_CNT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F98D8D1-6092-241D-E053-F662850A98B7","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"12/5/17 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6037829","version":"1","preferredName":"Response Other Specify Text","preferredDefinition":"Text description to qualify a response of 'Other' to a question, requiring additonal information or a detailed explanation","longName":"OTH_SPEC_TXT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FA00D7A-C39A-7EEF-E053-F662850A6622","latestVersionIndicator":"Yes","beginDate":"2017-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-05","modifiedBy":"LISU","dateModified":"2023-08-16","changeNote":"12/5/17 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6080665","version":"1","preferredName":"Person Bilateral Arm Volume And Joint Mobility Measurement Performed Ind","preferredDefinition":"The response to indicate if arm volume and mobility measurements were done.","longName":"ARM_VOL_MOB_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65E8726D-53E5-127D-E053-F662850A6B15","latestVersionIndicator":"Yes","beginDate":"2018-02-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-23","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 2/23/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6084986","version":"1","preferredName":"Breast Carcinoma Histologic Surgical Margin Involvement Type","preferredDefinition":"The type of breast cancer pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in the surgical margins.","longName":"BRCA_HIST_SURG_MARG_INVLV_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"662108B3-7E9F-7AB8-E053-F662850A91E5","latestVersionIndicator":"Yes","beginDate":"2018-02-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-26","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 2/26/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6091952","version":"1","preferredName":"Person Right Arm Angle Between Lateral Chest Wall And Humerus Joint Mobility Measurement","preferredDefinition":"Numeric annotation to indicate right arm joint mobility of the angle between the lateral chest wall and humerus, measured in degrees.","longName":"ARM_ANGLE_RA","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66391515-992B-5D3F-E053-F662850A3E07","latestVersionIndicator":"Yes","beginDate":"2018-02-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-27","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 2/27/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6092249","version":"1","preferredName":"Person Left Arm Angle Between Lateral Chest Wall And Humerus Joint Mobility Measurement","preferredDefinition":"Numeric annotation to indicate left arm joint mobility of the angle between the lateral chest wall and humerus, measured in degrees.","longName":"ARM_ANGLE_LA","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6646CD16-99D7-4522-E053-F662850AE50F","latestVersionIndicator":"Yes","beginDate":"2018-02-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-28","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 2/28/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6102867","version":"1","preferredName":"Breast Sentinel Lymph Node Micrometastasis Measurement Present Count","preferredDefinition":"The quantity of breast sentinel nodes with micrometastases and size.","longName":"BR_SLN_MICRO_MEASR_CNT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C010F0-3FF7-6D91-E053-F662850A14C0","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-06","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/6/18 tt/m39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6102901","version":"1","preferredName":"Breast Sentinel Lymph Node Macrometastasis Measurement Present Count","preferredDefinition":"The quantity of breast sentinel nodes with macrometastases and size.","longName":"BR_SLN_MACRO_MEASR_CNT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66B7D558-97DF-0E56-E053-F662850A2D78","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-06","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/6/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6106699","version":"1","preferredName":"Breast Sentinel Lymph Nodes Isolated Tumor Cells Measurement Present Count","preferredDefinition":"The quantity of breast sentinel nodes with isolated tumor cells and size.","longName":"BR_SLN_ISOL_TUMCL_MEASR_CNT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C0C87E-5363-22E1-E053-F662850A5115","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-06","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/6/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6112116","version":"1","preferredName":"Breast Carcinoma Sentinel Lymph Node Extranodal Involvement Ind","preferredDefinition":"Indicator for the extension of breast carcinoma beyond the sentinel lymph node capsule.","longName":"BRCA_SLN_EXNOD_INV_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C43CDB-733A-0B9A-E053-F662850AA6C4","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-06","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/6/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6112285","version":"1","preferredName":"Breast Carcinoma Sentinel Lymph Node Extranodal Involvement Type","preferredDefinition":"A response for the type of breast carcinoma extension beyond the sentinel lymph node capsule.","longName":"BRCA_SLN_EXNOD_INV_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C55AF4-80D4-3F57-E053-F662850AA4E3","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-06","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113694","version":"1","preferredName":"Lymph Node Positive Finding Count","preferredDefinition":"The quantity of positive lymph nodes confirming the presence of a disease.","longName":"LN_POS_FIND_CT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D13644-6F52-68D6-E053-F662850A256D","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"CLOHNES","dateModified":"2023-11-21","changeNote":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":"11/21/23 Added 2 alt OID for CCTG ticket number CADSR0003101 cjl; 11/01/23 Added 2 AQT for CCTG ticket number CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113696","version":"1","preferredName":"Breast Carcinoma Lymph Node Largest Metastasis Diameter Measurement","preferredDefinition":"Numeric annotation to indicate the largest diameter of lymph node metastases measured in mm.","longName":"BRCA_LN_LRG_METS_DIAM_MSRMT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D26E73-34F7-6D82-E053-F662850AC6B1","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113723","version":"1","preferredName":"Breast Carcinoma Sentinel Lymph Node Largest Metastasis Diameter Measurement","preferredDefinition":"Numeric annotation to indicate the largest diameter of sentinel lymph node metastases measured in mm.","longName":"BRCA_SLN_LRG_METS_DIAM_MSRMT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D31806-1378-5AE4-E053-F662850A532E","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113759","version":"1","preferredName":"Sentinel Lymph Node Positive Finding Count","preferredDefinition":"The quantity of positive sentinel nodes confirming the presence of a disease.","longName":"SLN_POS_FIND_CT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D63326-9B2E-732A-E053-F662850A452C","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113766","version":"1","preferredName":"Breast Carcinoma Extranodal Involvement Ind","preferredDefinition":"Indicator for the extension of breast carcinoma beyond the lymph node capsule.","longName":"BRCA_EXNOD_INV_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D24FDC-1930-68D2-E053-F662850A5FF7","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113776","version":"1","preferredName":"Breast Lymph Node Macrometastasis Measurement Present Count","preferredDefinition":"The quantity of breast lymph nodes with macrometastases and size.","longName":"BR_LN_MACRO_MEASR_CNT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D615F5-AF83-193F-E053-F662850A8993","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113788","version":"1","preferredName":"Breast Lymph Node Micrometastasis Measurement Present Count","preferredDefinition":"The quantity of breast lymph nodes with micrometastases and size.","longName":"BR_LN_MICRO_MEASR_CNT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D615F5-AFC0-193F-E053-F662850A8993","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"CLOHNES","dateModified":"2023-01-19","changeNote":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113791","version":"1","preferredName":"Breast Lymph Node Isolated Tumor Cells Measurement Present Count","preferredDefinition":"The quantity of breast lymph nodes with isolated tumor cells and size.","longName":"BR_LN_ISOL_TUMCL_MEASR_CNT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D819F7-486C-0BA3-E053-F662850AFA6A","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113792","version":"1","preferredName":"Breast Carcinoma Extranodal Involvement Type","preferredDefinition":"A response for the type of breast carcinoma extension beyond the lymph node capsule.","longName":"BRCA_LN_EXNOD_INV_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D829AF-D88A-0608-E053-F662850A742F","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6115763","version":"1","preferredName":"Breast Carcinoma Histologic Grade","preferredDefinition":"The histologic tumor grade for the measure of differentiation in breast cancer cells.","longName":"BRCA_HIST_GD","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D24FDC-1970-68D2-E053-F662850A5FF7","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6117719","version":"1","preferredName":"Breast Carcinoma Estrogen Receptor Status","preferredDefinition":"The estrogen receptor status of a primary breast tumor or metastases.","longName":"BRCA_ER_STAT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D7C518-F8A3-65E5-E053-F662850A5C83","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-08","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/8/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6117728","version":"1","preferredName":"Breast Carcinoma Progesterone Receptor Status","preferredDefinition":"The progesterone receptor status of a primary breast tumor or metastases.","longName":"BRCA_PGR_STAT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66E7B50F-7C49-2466-E053-F662850ABFFC","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-08","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/8/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6117739","version":"1","preferredName":"Breast Carcinoma HER2/Neu Gene Expression Immunohistochemical Test HER2/Neu Gene Immunohistochemical Test Status","preferredDefinition":"Information related to the status of the breast carcinoma HER2/neu gene expression immunochemical test.","longName":"BRCA_HNEU_EXP_IMUHIST_STAT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66DBDD3D-6AA5-2F95-E053-F662850AB7C1","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-08","modifiedBy":"CLOHNES","dateModified":"2023-05-10","changeNote":"11/26/18 TT released/CWinch. 3/8/18 tt/MA39.","administrativeNotes":"5/10/23 added human readable def per CCTG cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6118090","version":"1","preferredName":"Imaging Procedure Performed Outcome","preferredDefinition":"The result of any imaging method that aids in the visualization of a biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","longName":"IMG_PROC_OUTCM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66ED7F1C-081C-6F5C-E053-F662850A90AD","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-08","modifiedBy":"WINCHC","dateModified":"2022-02-10","changeNote":"11/26/18 TT released/CWinch. 3/8/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6118203","version":"1","preferredName":"Index Breast Carcinoma Surgical Procedure Performed Ind","preferredDefinition":"The indicator response as to whether surgery was performed on the index breast cancer.","longName":"INDX_BRCA_SGY_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EE823E-59F5-4E0B-E053-F662850A6D41","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-08","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/8/18 tt/MA39","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6118213","version":"1","preferredName":"Laboratory Procedure HER2/neu Fluorescence in situ Hybridization Outcome HER2/Neu by FISH Status","preferredDefinition":"information relating to the result (outcome) of a laboratory test (a medical procedure that involves testing a sample of blood, urine, or other substance from the body) using fluorescence in situ hybridization (FISH; a type of in situ hybridization in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy) to determine the level of HER2/neu (the ERBB2 gene at 17q21.1 which encodes ERRB2 receptor protein tyrosine kinase)._A condition or state at a particular time.","longName":"HER2_FISH_STAT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EE823E-5A28-4E0B-E053-F662850A6D41","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-08","modifiedBy":"WINCHC","dateModified":"2019-01-28","changeNote":"11/26/18 TT released/CWinch. 3/8/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6132657","version":"1","preferredName":"Breast Oncoplastic Surgical Procedure Mammoplasty Performed Ind","preferredDefinition":"The indicator response determining whether certain stated circumstances exist or criteria are satisfied with regards to the performance of breast oncoplastic and reconstruction surgeries.","longName":"ONCSGY_MPLSTY_PERF_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"674A5C14-B61C-6C5F-E053-F662850A76E9","latestVersionIndicator":"Yes","beginDate":"2018-03-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-13","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/13/18 tt/mA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6132666","version":"1","preferredName":"Breast Mammoplasty Performed Type","preferredDefinition":"The type of breast surgical reconstruction performed.","longName":"MPLSTY_PERF_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6749EACB-228E-3571-E053-F662850A16EC","latestVersionIndicator":"Yes","beginDate":"2018-03-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-13","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/13/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6132670","version":"2","preferredName":"Breast Surgical Procedure Performed Type","preferredDefinition":"A response for the type of surgery performed on the breast.","longName":"BR_SGY_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0529F05C-5E23-6EBE-E063-731AD00A90D2","latestVersionIndicator":"Yes","beginDate":"2018-03-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-09-12","modifiedBy":"CLOHNES","dateModified":"2023-09-12","changeNote":"11/26/18 TT released/CWinch. 3/15/18 tt/MA39.","administrativeNotes":"9/12/23 Major version change of CDE due to minor version change of VD due to increase max length to 100 due to cleanup efforts cjl.","unresolvedIssues":"9/12/23 Major version change of CDE due to minor version change of VD due to increase max length to 100 due to cleanup efforts cjl.","deletedIndicator":"No"},{"publicId":"6133247","version":"1","preferredName":"Histologic Invasive Breast Cancer Modified Nottingham Grade","preferredDefinition":"Tumor grade according to the modified Nottingham grading system for invasive breast carcinoma.","longName":"HIST_INV_BRCA_MOD_NHAM_GD","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"675F5EE9-5AB9-2B9D-E053-F662850ABB49","latestVersionIndicator":"Yes","beginDate":"2018-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-14","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/C Winch. 3/14/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6133687","version":"1","preferredName":"Breast Side Surgical Procedure Location Anatomic Site","preferredDefinition":"The response for which breast the surgical procedure was performed on.","longName":"BR_SGY_SITE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6766C7C7-8F7C-269B-E053-F662850A8115","latestVersionIndicator":"Yes","beginDate":"2018-03-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-15","modifiedBy":"MORENOC","dateModified":"2019-02-26","changeNote":"11/26/18 TT released/CWinch. 3/18/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6134043","version":"1","preferredName":"Prior Adjuvant Systemic Therapy Index Malignant Neoplasm Administration Ind","preferredDefinition":"The indicator response to address the prior administration of adjuvant systemic treatments for the index cancer.","longName":"PTHER_ADJ_INDX_CA_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6777A8CF-1CEE-7040-E053-F662850A5515","latestVersionIndicator":"Yes","beginDate":"2018-03-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-15","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/15/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6134061","version":"1","preferredName":"Prior Intervention Continue Ind","preferredDefinition":"The indicator response as to whether the prior activity that produces an effect, or that is intended to alter the course of a disease in the patient is ongoing.","longName":"PR_INTVN_CONT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6777DC7A-AC25-773D-E053-F662850A26C0","latestVersionIndicator":"Yes","beginDate":"2018-03-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-15","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/15/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6143229","version":"1","preferredName":"Person Medical History Major Problem Type","preferredDefinition":"A response for the patient's history regarding the types of major medical conditions, disorders, and disease events.","longName":"MMP_PROB","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67DCBF1D-15D7-7A2D-E053-F662850A2DB5","latestVersionIndicator":"Yes","beginDate":"2018-03-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-20","modifiedBy":"WINCHC","dateModified":"2022-03-08","changeNote":"11/26/18 TT released/CWinch. 3/20/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6148351","version":"1","preferredName":"Imaging Technique Investigation Performed Imaging Type","preferredDefinition":"A description of the type of imaging technique performed.","longName":"IMG_INV_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"681AD81D-96F5-233B-E053-F662850A8D57","latestVersionIndicator":"Yes","beginDate":"2018-03-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-23","modifiedBy":"TSESU","dateModified":"2023-11-27","changeNote":"11/26/18 TT released/CWinch. 3/23/18 tt/MA39.","administrativeNotes":"5/8/23 added human readable def for CCTG during cleanup activities cjl; 1/24/23 added AQT for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6148596","version":"1","preferredName":"Person Medical History Major Problem Other Details Text","preferredDefinition":"Free text field for other details related to the patient's medical history of major medical conditions, disorders, and disease events.","longName":"MMP_DET","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"682A2072-8046-7812-E053-F662850A52B3","latestVersionIndicator":"Yes","beginDate":"2018-03-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-24","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 3/24/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6148673","version":"1","preferredName":"Person Correlative Study Specimen Submission And Collection Information Complete Ind","preferredDefinition":"The response to indicate whether the correlative study information related to specimen submission and collection was completed.","longName":"CS_INF_COMP_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"683CA22A-1C29-113D-E053-F662850A4BE2","latestVersionIndicator":"Yes","beginDate":"2018-03-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-25","modifiedBy":"CLOHNES","dateModified":"2023-02-23","changeNote":"11/26/18 TT released/CWinch. 3/25/18 tt/mA39.","administrativeNotes":"2/23/23 added AQT for CCTG ticket number CADSR0002081 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6148677","version":"1","preferredName":"Person Clinical Trial Protocol Questionnaire Complete Ind","preferredDefinition":"The indicator to address the completion of clinical trial questionnaire(s).","longName":"QSTR_COMP_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"683CDFDE-CAFC-7E26-E053-F662850A76F3","latestVersionIndicator":"Yes","beginDate":"2018-03-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-25","modifiedBy":"TAYLORT","dateModified":"2018-04-03","changeNote":"3/25/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6148685","version":"1","preferredName":"Person Clinical Trial Protocol Questionnaire Complete Date","preferredDefinition":"Completion date for the protocol questionnaire(s).","longName":"QSTR_COMP_DT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"683DA698-272D-05D8-E053-F662850ACD47","latestVersionIndicator":"Yes","beginDate":"2018-03-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-25","modifiedBy":"WINCHC","dateModified":"2022-04-28","changeNote":"3/25/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6148865","version":"1","preferredName":"Follow-up Patient Visit Malignant Neoplasm Occurrence Type","preferredDefinition":"The type of patient follow-up visit with regards to cancer occurrence.","longName":"VIS_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6850673E-D13E-0BA9-E053-F662850A7713","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-26","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 3/26/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6160859","version":"1","preferredName":"Lost Productivity Gross Income Per Year Category","preferredDefinition":"Lost productivity yearly gross income.","longName":"LP_INC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68F7B2DE-2633-4EED-E053-F662850A02B0","latestVersionIndicator":"Yes","beginDate":"2018-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-03","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 4/3/18 tt/MA39","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6160865","version":"1","preferredName":"Lost Productivity Medical Insurance Type","preferredDefinition":"Lost productivity type of medical insurance.","longName":"6160818v1.0:6160648v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68F7C038-4923-489E-E053-F662850A6CDB","latestVersionIndicator":"Yes","beginDate":"2018-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-03","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":"11-21-18 TT released/CWinch. 4/3/18 tt/MA39.","administrativeNotes":"7/1/22 added alt OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6160866","version":"1","preferredName":"Lost Productivity Employment Description Type","preferredDefinition":"Lost productivity type of employment.","longName":"6160821v1.0:6160806v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68F7E818-15D1-4BBA-E053-F662850A3DEA","latestVersionIndicator":"Yes","beginDate":"2018-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-03","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":"11-21-18 TT released/CWinch. 4/3/18 tt/MA39.","administrativeNotes":"7/1/22 added alt OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6160868","version":"1","preferredName":"Lost Productivity Prior Employment Status","preferredDefinition":"The state of lost productivity for prior employment status.","longName":"6160824v1.0:6160814v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68F808CD-EEAD-46E0-E053-F662850AF86F","latestVersionIndicator":"Yes","beginDate":"2018-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-03","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 4/3/18 tt/MA39","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161101","version":"1","preferredName":"Person Bilateral Arm Volume And Range of Motion Measurement Point Loading Ind","preferredDefinition":"The response to indicate if arm volume and mobility measurements points are to be loaded.","longName":"ARM_LOAD_POINT_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6907D65A-56C9-63E4-E053-F662850A446A","latestVersionIndicator":"Yes","beginDate":"2018-04-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-04","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 4/4/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161321","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 1 Past 7 Days How Difficult to Push or Pull Large Objects with Affected Arm Score 5 Point Scale","preferredDefinition":"A person's stated observation of how difficult it has been in the past 7 days to push or pull large objects, like a living room chair, with their affected arm, using a 5-point Likert scale.","longName":"ARM_BRST_1_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"691197B6-E610-5C48-E053-F662850A8542","latestVersionIndicator":"Yes","beginDate":"2018-04-04","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-04","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161322","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 2 Past 7 Days How Difficult to Lift Items over 10 Pounds with Affected Arm Score 5 Point Scale","preferredDefinition":"A person's stated observation of how difficult it has been in the past 7 days to lift items over 10 pounds, like a heavy bag or groceries with their affected arm, using a 5-point Likert scale.","longName":"ARM_BRST_2_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69129816-F08F-5C40-E053-F662850A9B0A","latestVersionIndicator":"Yes","beginDate":"2018-04-04","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-04","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161323","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 3 Past 7 Days How Difficult to Reach or Extend Affected Arm Above Shoulder Level Score 5 Point Scale","preferredDefinition":"A person's stated observation of how difficult it has been in the past 7 days to reach or extend their affected arm above shoulder level, using a 5-point Likert scale.","longName":"ARM_BRST_3_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6911AE25-9C66-6FD1-E053-F662850A2FE3","latestVersionIndicator":"Yes","beginDate":"2018-04-04","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-04","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11-26-18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161324","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 4 Past 7 Days How Difficult to Wash Back with Affected Arm Score 5 Point Scale","preferredDefinition":"A person's stated observation of how difficult it has been in the past 7 days to wash their back with their affected arm, using a 5-point Likert scale.","longName":"ARM_BRST_4_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"691153BE-8492-7A5D-E053-F662850A8CC3","latestVersionIndicator":"Yes","beginDate":"2018-04-04","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-04","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161325","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 5 Past 7 Days How Difficult to Bend and Straighten Affected Arm Score 5 Point Scale","preferredDefinition":"A person's stated observation of how difficult it has been in the past 7 days to bend and straighten their affected arm, using a 5-point Likert scale.","longName":"ARM_BRST_5_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"691153BE-84C3-7A5D-E053-F662850A8CC3","latestVersionIndicator":"Yes","beginDate":"2018-04-04","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-04","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161326","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 6 Past 7 Days How Much Bothered by Tenderness in Affected Underarm, Arm, or Hand Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by tenderness in their affected underarm, arm or hand, using a 5-point Likert scale.","longName":"ARM_BRST_6_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"691153BE-84EB-7A5D-E053-F662850A8CC3","latestVersionIndicator":"Yes","beginDate":"2018-04-04","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-04","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161327","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 7 Past 7 Days How Much Bothered by Swelling in Affected Underarm, Arm, or Hand Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by swelling in their affected underarm, arm or hand, using a 5-point Likert scale.","longName":"ARM_BRST_7_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"691197B6-E638-5C48-E053-F662850A8542","latestVersionIndicator":"Yes","beginDate":"2018-04-04","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-04","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161328","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 8 Past 7 Days How Much Bothered by Numbness in Affected Underarm, Arm, or Hand Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by numbness in their affected underarm, arm or hand, using a 5-point Likert scale.","longName":"ARM_BRST_8_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6911EEC3-74FD-77A1-E053-F662850AB2BD","latestVersionIndicator":"Yes","beginDate":"2018-04-04","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-04","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161329","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 9 Past 7 Days How Much Bothered by Tingling in Affected Underarm, Arm, or Hand Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by tingling sensation (\"pins & needles\") in their affected underarm, arm or hand, using a 5-point Likert scale.","longName":"ARM_BRST_9_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"691197B6-E660-5C48-E053-F662850A8542","latestVersionIndicator":"Yes","beginDate":"2018-04-04","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-04","modifiedBy":"CLOHNES","dateModified":"2023-05-09","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":"5/9/23- removed artifacts from def and PQT for CCTG cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161330","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 10 Past 7 Days How Much Bothered by Increased Skin Sensitivity in Affected Underarm, Arm, or Hand Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by increased skin sensitivity in their affected underarm, arm or hand, using a 5-point Likert scale.","longName":"ARM_BRST_10_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"691197B6-E688-5C48-E053-F662850A8542","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161331","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 11 Past 7 Days How Much Bothered by Tightness, Pulling, or Stretching in Affected Underarm, Arm, or Hand Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by tightness, pulling, or stretching in their affected underarm, arm or hand, using a 5-point Likert scale.","longName":"ARM_BRST_11_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6913085F-D64E-5C3C-E053-F662850A1979","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161332","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 12 Past 7 Days How Much Bothered by Discomfort or Pain in Affected Underarm, Arm, or Hand Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by discomfort or pain in their affected underarm, arm or hand, using a 5-point Likert scale.","longName":"ARM_BRST_12_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6913085F-D676-5C3C-E053-F662850A1979","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161333","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 13 Past 7 Days How Much Bothered by Arm Weakness in Affected Arm Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by arm weakness in their affected underarm, arm or hand, using a 5-point Likert scale.","longName":"ARM_BRST_13_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69135267-2176-6857-E053-F662850A497A","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161334","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 14 Past 7 Days How Much Bothered by Arm Heaviness in Affected Arm Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by arm heaviness in their affected underarm, arm or hand, using a 5-point Likert scale.","longName":"ARM_BRST_14_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69135ABB-B9E7-4422-E053-F662850AC2DA","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161335","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 15 Past 7 Days How Much Bothered by Shoulder Stiffness in Affected Arm Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by shoulder stiffness in their affected underarm, arm or hand, using a 5-point Likert scale.","longName":"ARM_BRST_15_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69129816-F0B7-5C40-E053-F662850A9B0A","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161336","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 16 Past 7 Days How Much Bothered by Tenderness in Affected Breast or Chest Area Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by tenderness in their affected breast or chest area, using a 5-point Likert scale.","longName":"ARM_BRST_16_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69135267-219E-6857-E053-F662850A497A","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161337","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 17 Past 7 Days How Much Bothered by Swelling in Affected Breast or Chest Area Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by swelling in their affected breast or chest area, using a 5-point Likert scale.","longName":"ARM_BRST_17_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69135ABB-BA0F-4422-E053-F662850AC2DA","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161338","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 18 Past 7 Days How Much Bothered by Numbness in Affected Breast or Chest Area Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by numbness in their affected breast or chest area, using a 5-point Likert scale.","longName":"ARM_BRST_18_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69135ABB-BA37-4422-E053-F662850AC2DA","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161339","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 19 Past 7 Days How Much Bothered by Tingling in Affected Breast or Chest Area Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by tingling sensation (\"pins & needles\") in their affected breast or chest area, using a 5-point Likert scale.","longName":"ARM_BRST_19_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6913085F-D69E-5C3C-E053-F662850A1979","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"CLOHNES","dateModified":"2023-05-09","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":"5/9/23 Removed artifacts from def and pref quest text per CCTG cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161340","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 20 Past 7 Days How Much Bothered by Increased Skin Sensitivity in Affected Breast or Chest Area Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by increased skin sensitivity in their affected breast or chest area, using a 5-point Likert scale.","longName":"ARM_BRST_20_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69129816-F0DF-5C40-E053-F662850A9B0A","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161341","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 21 Past 7 Days How Much Bothered by Tightness, Pulling, or Stretching in Affected Breast or Chest Area Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by tightness, pulling, or stretching in their affected breast or chest area, using a 5-point Likert scale.","longName":"ARM_BRST_21_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69141578-FEC1-4330-E053-F662850A5D16","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161342","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 22 Past 7 Days How Much Bothered by Discomfort or Pain in Affected Breast or Chest Area Score 5 Point Scale","preferredDefinition":"A person's stated observation of how much they have been bothered in the past 7 days by discomfort or pain in their affected breast or chest area, using a 5-point Likert scale.","longName":"ARM_BRST_22_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6911A6F3-DCC4-5C4C-E053-F662850A8DBD","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161343","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 23 Past 7 Days Extent Breast Cancer Treatment Disrupted Social Activities with Family and Friends Score 5 Point Scale","preferredDefinition":"A person's stated observation to what extent, in the past 7 days, the effect of breast cancer treatment on their arm has disrupted social activities with family and friends, using a 5-point Likert scale.","longName":"ARM_BRST_23_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69135ABB-BA5F-4422-E053-F662850AC2DA","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161344","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 24 Past 7 Days Extent Breast Cancer Treatment Disrupted Work Score 5 Point Scale","preferredDefinition":"A person's stated observation to what extent, in the past 7 days, the effect of breast cancer treatment on their arm has disrupted work (including housework), using a 5-point Likert scale.","longName":"ARM_BRST_24_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6914452E-F1B4-6A6A-E053-F662850A8745","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161345","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 25 Past 7 Days Extent Breast Cancer Treatment Disrupted Recreational Activities Score 5 Point Scale","preferredDefinition":"A person's stated observation to what extent, in the past 7 days, the effect of breast cancer treatment on their arm has disrupted recreational activities, using a 5-point Likert scale.","longName":"ARM_BRST_25_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69135ABB-BA87-4422-E053-F662850AC2DA","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161346","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 26 Past 7 Days Extent Breast Cancer Treatment Disrupted Self-care Score 5 Point Scale","preferredDefinition":"A person's stated observation to what extent, in the past 7 days, the effect of breast cancer treatment on their arm has disrupted self-care (bathing, dressing), using a 5-point Likert scale.","longName":"ARM_BRST_26_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69135ABB-BAAF-4422-E053-F662850AC2DA","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161347","version":"1","preferredName":"Arm and Breast Symptom Questionnaire 27 Past 7 Days Extent Breast Cancer Treatment Disrupted Normal Sleep Score 5 Point Scale","preferredDefinition":"A person's stated observation to what extent, in the past 7 days, the effect of breast cancer treatment on their arm has disrupted normal sleep, using a 5-point Likert scale.","longName":"ARM_BRST_27_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69132A2E-4472-41A7-E053-F662850AB56C","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"TSESU","dateCreated":"2018-04-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. Created for CCTG MA.39 - smt 4/3/18.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161764","version":"1","preferredName":"Therapeutic Procedure Administered Name","preferredDefinition":"The name of the therapeutic agent administered that is intended to alter or stop a pathologic process","longName":"TRT_NAM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"692F102C-902F-2A09-E053-F662850A9C0C","latestVersionIndicator":"Yes","beginDate":"2018-04-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-06","modifiedBy":"CLOHNES","dateModified":"2023-02-23","changeNote":"11/26/18 TT released/CWinch. 4/6/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6162638","version":"1","preferredName":"Breast Laterality Anatomic Site","preferredDefinition":"The named location for breast laterality.","longName":"BR_LAT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6930F182-1B32-0AB9-E053-F662850A0E93","latestVersionIndicator":"Yes","beginDate":"2018-04-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-06","modifiedBy":"KNABLEJ","dateModified":"2019-05-14","changeNote":"11/26/18 TT released/CWinch. 4/6/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6162642","version":"1","preferredName":"Recurrent Disease Imaging Assessment Ind","preferredDefinition":"The indicator response as to whether recurrence was assessed by an imaging procedure.","longName":"RDZ_IMG_ASS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"693159A8-459D-0AA1-E053-F662850A3745","latestVersionIndicator":"Yes","beginDate":"2018-04-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-06","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 4/6/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6183402","version":"1","preferredName":"Sick Leave Begin Date","preferredDefinition":"The date when sick leave started.","longName":"6183401v1.0:2018550v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"698377C4-778C-2C50-E053-F662850A1EB9","latestVersionIndicator":"Yes","beginDate":"2018-04-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-10","modifiedBy":"CLOHNES","dateModified":"2022-07-13","changeNote":"11/26/18 TT released/CWinch. 4/10/18 tt/MA39","administrativeNotes":"7/1/22 added 2 alt OID, CCTG cjl; 7/13/22 added 2 AQTs for CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6183414","version":"1","preferredName":"Disability Leave Begin Date","preferredDefinition":"The date when disability leave started.","longName":"6183410v1.0:2018550v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69838E7C-2DBF-3588-E053-F662850A1EF2","latestVersionIndicator":"Yes","beginDate":"2018-04-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-10","modifiedBy":"CLOHNES","dateModified":"2022-07-13","changeNote":"11/26/18 TT released/CWinch. 4/10/18 tt/MA39.","administrativeNotes":"7/1/22 added alt OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6183483","version":"1","preferredName":"Lost Productivity Current Employment Status","preferredDefinition":"Lost productivity present employment status.","longName":"6160827v1.0:6160814v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69848C7C-E920-2254-E053-F662850AD170","latestVersionIndicator":"Yes","beginDate":"2018-04-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-10","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 4/10/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6183492","version":"1","preferredName":"Lost Productivity Employment Change Status","preferredDefinition":"Lost productivity change in employment status.","longName":"6160831v1.0:6183486v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6984E269-3A3B-3067-E053-F662850A410D","latestVersionIndicator":"Yes","beginDate":"2018-04-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-10","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":"11/26/18 TT released/CWinch. 4/10/18/ tt/MA39.","administrativeNotes":"7/1/22 added alt OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6183500","version":"1","preferredName":"Lost Productivity Employment Missed Category","preferredDefinition":"Lost productivity category for missed employment.","longName":"6160834v1.0:6183495v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6985BE8B-924E-3021-E053-F662850AEF2D","latestVersionIndicator":"Yes","beginDate":"2018-04-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-10","modifiedBy":"CLOHNES","dateModified":"2023-06-14","changeNote":"11/26/18 TT released/CWinch. 4/10/18 tt/MA39.","administrativeNotes":"7/1/22 added AQT for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6183623","version":"1","preferredName":"Lost Productivity Unemployment Missed Category","preferredDefinition":"Lost productivity category for missed unemployment.","longName":"6160837v1.0:6183495v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69941774-7A72-6D04-E053-F662850AF0F1","latestVersionIndicator":"Yes","beginDate":"2018-04-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-11","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":"11/26/18 TT released/CWinch. 4/11/18 tt/MA39.","administrativeNotes":"7/1/22 added AQT for CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6183727","version":"1","preferredName":"Specimen Not Collected Reason","preferredDefinition":"The reason a specimen was not collected.","longName":"SPEC_REAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A71E20-6597-3966-E053-F662850A1335","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"WINCHC","dateModified":"2022-04-29","changeNote":"11/26/18 TT released/CWinch. 4/12/18 tt/MA39","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6183743","version":"1","preferredName":"Laboratory Specimen Collection Status","preferredDefinition":"The state of specimen collection at a particular time.","longName":"SPEC_DONE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A89460-7656-4317-E053-F662850A7016","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"WINCHC","dateModified":"2022-04-29","changeNote":"11/26/18 TT released/CWinch. 4/12/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6183767","version":"1","preferredName":"Unemployment Begin Date","preferredDefinition":"The date when unemployment began.","longName":"6183766v1.0:2018550v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69A93CAB-FD94-5903-E053-F662850A6634","latestVersionIndicator":"Yes","beginDate":"2018-04-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-12","modifiedBy":"CLOHNES","dateModified":"2023-10-17","changeNote":"11/26/18 TT released/CWinch. 4/12/18 tt/MA39.","administrativeNotes":"7/13/22 added aqt for CCTG for Chad Winch cjl; 7/13/22 added alt OID, CCTG for Chad Winch cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6224667","version":"1","preferredName":"Infectious Disorder Clinical Trial Eligibility Criteria Ind","preferredDefinition":"Clinical trial eligibility indicator for questions related to infectious disorders.","longName":"WEC_INFEC_UTI","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A375412-5F1D-41C4-E053-F662850A2A92","latestVersionIndicator":"Yes","beginDate":"2018-04-19","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-04-19","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"2018APR19CW - created for CE7","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6224677","version":"1","preferredName":"Patient Seizure Disorder And Negation Therapeutic Procedure Clinical Trial Eligibility Criteria Ind","preferredDefinition":"Clinical trial eligibility indicator for questions to address seizure disorder and not treated.","longName":"WEC_SEIZ_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A350840-911F-5972-E053-F662850A3838","latestVersionIndicator":"Yes","beginDate":"2018-04-19","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-04-19","modifiedBy":"TAYLORT","dateModified":"2018-11-21","changeNote":"11-21-18 TT released/CWinch. 2018APR19 - CW - Created for CE7","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6224678","version":"1","preferredName":"Patient Significant Intercurrent Illness Clinical Trial Eligibility Criteria Ind","preferredDefinition":"Clinical eligibility indicator for questions regarding intercurrent illness that would preclude participation on study, as outlined in protocol.","longName":"WEC_OTH_COND_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A353D67-E1F7-5370-E053-F662850ABB0B","latestVersionIndicator":"Yes","beginDate":"2018-04-19","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-04-19","modifiedBy":"SOKKERL","dateModified":"2023-02-13","changeNote":"2018APR19 - CW - Created for CE7","administrativeNotes":"12/20/22 added AQT for ticket number CADSR0001818 for CCTG cjl; 8/4/2022: fixed the box symbol in AQT_wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6228010","version":"1","preferredName":"Histologic Finding Text","preferredDefinition":"Text field for histologic evidence of disease.","longName":"6228009v1.0:2666622v2.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A48063D-25EF-1E8D-E053-F662850A07EA","latestVersionIndicator":"Yes","beginDate":"2018-04-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-20","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"4/20/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6228094","version":"1","preferredName":"Laboratory Specimen Submission Status","preferredDefinition":"A response as to whether the specimen was submitted.","longName":"6228093v1.0:6183760v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A4D0679-A471-38C9-E053-F662850AE2A6","latestVersionIndicator":"Yes","beginDate":"2018-04-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-20","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"4/20/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6228465","version":"1","preferredName":"Specimen Vial Submission Count","preferredDefinition":"The number of vials submitted for use in testing, examination, study, or diagnosis.","longName":"SPEC_NUM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A8502C9-1298-2E4E-E053-F662850A0C86","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"WINCHC","dateModified":"2022-04-29","changeNote":"11/26/18 TT released/CWinch. 4/23/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6229520","version":"1","preferredName":"Specimen Submission Question Communication Contact Source","preferredDefinition":"A description of the source of the communication contact for specimen submission questions.","longName":"6229516v1.0:6229518v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A86F836-F244-2E48-E053-F662850A85DC","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeNote":"11/26/18 TT released/CWinch. 4/34/18 tt/MA39.","administrativeNotes":"5/25/23 Added human readable def per cleanup activities for the CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6229532","version":"1","preferredName":"Specimen Collection Timepoint Identifier","preferredDefinition":"One or more characters used to identify the point in time when the specimen was collected.","longName":"SPEC_TIME","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A86A882-EA2C-5635-E053-F662850A380C","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"CLOHNES","dateModified":"2023-11-29","changeNote":"11/26/18 TT released/CWinch. 4/23/18 tt/MA39.","administrativeNotes":"11/29/23 Added alt OID for CCTG ticket number CADSR0003123 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6229714","version":"1","preferredName":"Breast Carcinoma Present Ind","preferredDefinition":"The indicator response for the presence of breast cancer.","longName":"2982611v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A98D582-6A8F-1664-E053-F662850ACCCE","latestVersionIndicator":"Yes","beginDate":"2018-04-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-24","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 4/24/18 tt/NA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6229721","version":"1","preferredName":"ROS1 Gene Mutation Detection Result","preferredDefinition":"The outcome for the detection of a change in the nucleotide sequence of the ROS1 gene.","longName":"6229719v1.0:6229720v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A8A7611-B336-1A09-E053-F662850A7C56","latestVersionIndicator":"Yes","beginDate":"2018-04-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-24","modifiedBy":"FORMBUILDER","dateModified":"2018-07-11","changeNote":"5/9/18 tt released/CCTG. 4/24/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6230246","version":"1","preferredName":"Questionnaire Not Complete Reason","preferredDefinition":"The explanation for why a questionnaire was not completed.","longName":"6230245v1.0:6025272v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A8980BE-3B04-5971-E053-F662850A7013","latestVersionIndicator":"Yes","beginDate":"2018-04-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-24","modifiedBy":"KUMMEROA","dateModified":"2023-11-22","changeNote":"11/26/18 TT released/CWinch. 4/24/18 tt/MA39.","administrativeNotes":"2023.11.22 Alt SNs added per ticket request CADSR0003109. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6230496","version":"1","preferredName":"Intervention or Procedure Performed Name","preferredDefinition":"The name of the activity performed to produce an effect, or that is intended to alter the course of a disease in a patient or population.","longName":"TRT_PROC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6AAE03FF-1E37-0B76-E053-F662850AD2BF","latestVersionIndicator":"Yes","beginDate":"2018-04-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-25","modifiedBy":"CLOHNES","dateModified":"2023-02-23","changeNote":"11/26/18 TT released/CWinch. 4/25/18 tt/MA39.","administrativeNotes":"2/23/23 added AQT for CCTG ticket number CADSR0002081 cjl; 5/31/22 added alt name OID,CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6230503","version":"1","preferredName":"Other Intervention or Procedure Performed Ind","preferredDefinition":"The indicator as to whether other activities that produce an effect, or intended to alter the course of a disease in a patient were performed.","longName":"6230502v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6AAE3C79-72F5-6F57-E053-F662850AAB1D","latestVersionIndicator":"Yes","beginDate":"2018-04-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-25","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"4/25/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6230505","version":"1","preferredName":"Intervention or Procedure Administered Anatomic Site","preferredDefinition":"The named location of or within the body for an activity that produces an effect, or that is intended to alter the course of a disease in a patient.","longName":"TRT_SITE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6AAEF7BD-D72D-2DC8-E053-F662850A9391","latestVersionIndicator":"Yes","beginDate":"2018-04-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-25","modifiedBy":"CLOHNES","dateModified":"2023-03-22","changeNote":"11/26/18 TT released/CWinch. 4/25/18 tt/CE7.","administrativeNotes":"added alt name OID, CCTG 5/31/22 CJL","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6230518","version":"1","preferredName":"Disease or Disorder Current Status","preferredDefinition":"Text term to describe the state of patient disease at the present time.","longName":"6230514v1.0:6230509v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6AB0F470-3245-42CB-E053-F662850A34BB","latestVersionIndicator":"Yes","beginDate":"2018-04-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-25","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"4/25/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6230535","version":"1","preferredName":"PDL1 Gene Mutation Detection Result","preferredDefinition":"The outcome for the detection of a change in the nucleotide sequence of the PDL1 gene.","longName":"6230534v1.0:6229720v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6AB144B4-3453-38FD-E053-F662850ADE08","latestVersionIndicator":"Yes","beginDate":"2018-04-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-25","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"4/25/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6230636","version":"1","preferredName":"Adverse Event Time of Death Present Ind","preferredDefinition":"The indicator response as to whether the adverse event was present at the time of death.","longName":"AE_PRES_DR_NA_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6AC394DB-B26A-6B9B-E053-F662850A0601","latestVersionIndicator":"Yes","beginDate":"2018-04-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-26","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 4/26/18 tt/CCTG Death Report","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242573","version":"1","preferredName":"Specimen Block Submission Count","preferredDefinition":"The number of blocks submitted.","longName":"SPEC_BLK_NUM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B176761-E18D-0CAE-E053-F662850A69D8","latestVersionIndicator":"Yes","beginDate":"2018-05-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-01","modifiedBy":"WINCHC","dateModified":"2022-04-28","changeNote":"11/26/18 TT released/CWinch. 5/1/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242595","version":"1","preferredName":"Malignant Neoplasm Therapeutic Procedure Needs Report Since Last Reported Ind","preferredDefinition":"The indicator as to whether there is a need to report cancer treatments since the last report.","longName":"CANC_TRT_REP_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B177254-9D03-7FC5-E053-F662850A7473","latestVersionIndicator":"Yes","beginDate":"2018-05-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-01","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 5/1/18 tt/MA39.","administrativeNotes":"12/12/23 Added AQT for CCTG ticket number CADSR0003182 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6260066","version":"1","preferredName":"PDL1 Gene Mutation Detection Value","preferredDefinition":"The numerical percentage for the change in the nucleotide sequence of the PDL1 gene.","longName":"6230534v1.0:6260062v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B3C3D6C-CB47-0D38-E053-F662850AE776","latestVersionIndicator":"Yes","beginDate":"2018-05-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-02","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"5/2/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6260072","version":"1","preferredName":"Biochemistry Case Report Form Additional Loading Ind","preferredDefinition":"The indicator response for the loading of an additional biochemistry form.","longName":"6260071v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B3CC012-7B74-5D48-E053-F662850A2360","latestVersionIndicator":"Yes","beginDate":"2018-05-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-02","modifiedBy":"MMADDINENI","dateModified":"2023-05-09","changeNote":"5/2/18 tt/CE7.","administrativeNotes":"05/09/2023-Added AQT and Alt OID(CADSR002395)-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6260087","version":"1","preferredName":"Corticosteroid Indication Reason","preferredDefinition":"The explanation for the initiation of corticosteroids.","longName":"6260080v1.0:6260076v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B3E20B8-610E-3505-E053-F662850A69DA","latestVersionIndicator":"Yes","beginDate":"2018-05-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-02","modifiedBy":"WINCHC","dateModified":"2022-02-02","changeNote":"5/2/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6265645","version":"1","preferredName":"Clinical Trial Intervention or Procedure Negation Administration Decision Date","preferredDefinition":"The date on which the decision was made to not administer research study therapy.","longName":"6265644v1.0:2018550v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B616C7A-89D2-154D-E053-F662850A1624","latestVersionIndicator":"Yes","beginDate":"2018-05-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-04","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 5/4/18 tt/MA39.","administrativeNotes":"12/12/23 Added AQT for CCTG ticket number CADSR0003179 cjl; 11/7/23 Added AQT for CCTG for ticket number CADSR0003018 cjl; 5/31/22 added alt name OID, CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6265649","version":"1","preferredName":"Clinical Trial Intervention or Procedure Negation Administration Reason","preferredDefinition":"An explanation for why the research study therapy was not administered.","longName":"6265647v1.0:6265648v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B61B893-358B-5809-E053-F662850A8954","latestVersionIndicator":"Yes","beginDate":"2018-05-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-04","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 5/4/18 tt/MA39.","administrativeNotes":"12/12/23 Added AQT for CCTG ticket number CADSR0003179 cjl; 11/7/23 Added AQT and alt OID for CCTG for ticket number CADSR0003018 cjl; 5/31/22 added alt name OID, CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6266232","version":"1","preferredName":"Radiation Therapy First Fractionation Date","preferredDefinition":"Date for the first fraction treatment of a disease by means of exposure to radiation.","longName":"6266231v1.0:2018550v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B618D71-C97C-1556-E053-F662850AF0D3","latestVersionIndicator":"Yes","beginDate":"2018-05-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-04","modifiedBy":"CLOHNES","dateModified":"2023-02-01","changeNote":"11/26/18 TT released/CWinch. 5/4/18 tt/MA39.","administrativeNotes":"2/1/23 added alt OID, CCTG for ticket number CADSR0001948 cjl; 1/24/23 added AQT for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6266251","version":"1","preferredName":"Radiation Therapy Last Fractionation Date","preferredDefinition":"Date for the last fraction treatment of a disease by means of exposure to radiation.","longName":"6266235v1.0:2018550v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B62603E-72C7-6F35-E053-F662850AD552","latestVersionIndicator":"Yes","beginDate":"2018-05-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-04","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 5/4/18 tt/MA39.","administrativeNotes":"12/12/23 Added alt OID and AQT for CCTG ticket number CADSR0003179 cjl; 2/1/23 added alt, OID, CCTG for ticket number CADSR0001948 cjl; 1/24/23 added AQT for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270460","version":"1","preferredName":"Boost Radiation Therapy Administered Total Dose","preferredDefinition":"The total dose of supplemental radiation given to a specific area of interest, often to the tumor site itself.","longName":"6270459v1.0:2015807v3.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA144DA-408A-6AA9-E053-F662850A23B7","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/7/18 tt/MA39","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270461","version":"1","preferredName":"Boost Radiation Therapy Administered Ind","preferredDefinition":"The indicator as to whether supplemental radiation was given to a specific area of interest, often to the tumor site itself.","longName":"6270459v1.0:3506034v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA278A6-CF37-53B8-E053-F662850AE56F","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-07","modifiedBy":"TSESU","dateModified":"2023-04-12","changeNote":"11/26/18 TT released/CWinch. 5/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270471","version":"1","preferredName":"Boost Radiation Therapy Total Fractionation Adminstered Count","preferredDefinition":"The quantity of fractionation radiotherapy administered to the boost specific area of interest.","longName":"6270470v1.0:2018595v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA2A635-3FA9-1888-E053-F662850A63DC","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270491","version":"1","preferredName":"Boost Radiation Therapy Administered Timepoint Identifier","preferredDefinition":"One or more characters used to identify the point in time when the supplemental radiation was given to a specific area of interest.","longName":"6270459v1.0:6270490v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA41440-DEC4-6747-E053-F662850A0990","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-07","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"5/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270630","version":"1","preferredName":"Total Dose Radiation Therapy Prior To Boost Radiotherapy Dose","preferredDefinition":"The quantity of radiation therapy administered before the extra radiation treatments targeted at the tumor bed, given after the regular sessions of radiation are complete.","longName":"6267202v1.0:2015807v3.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BB227C2-9517-6BFF-E053-F662850AFEAC","latestVersionIndicator":"Yes","beginDate":"2018-05-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-08","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/8/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270766","version":"1","preferredName":"Intervention or Procedure Administered Adhere To Clinical Trial Protocol Ind","preferredDefinition":"The indicator as to whether the activity that produces an effect, or that is intended to alter the course of a disease in a patient was given in accordance with the study protocol.","longName":"6270765v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BB3E8C8-A210-713D-E053-F662850A7B50","latestVersionIndicator":"Yes","beginDate":"2018-05-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-08","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"5/8/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270781","version":"1","preferredName":"Radiation Therapy Interruption Reason","preferredDefinition":"An explanation for the temporary cessation of radiation therapy.","longName":"2014277v2.0:6270774v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BB598D6-5E7C-4A72-E053-F662850AD6D5","latestVersionIndicator":"Yes","beginDate":"2018-05-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-08","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 5/8/18 tt/MA39.","administrativeNotes":"12/12/23 Added alt OID for CCTG ticket number CADSR0003179 cjl; added alt name OID, CCTG and AQT 5/31/22 cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270898","version":"1","preferredName":"Clinical Study Radiation Therapy Dose Modification Ind","preferredDefinition":"The indicator as to whether there were any changes or adjustments made to the study RT dose specified in the treatment plan and/or administered to the patient.","longName":"RT_DOSE_ADJ","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BB6C9E2-3610-6BBD-E053-F662850A541B","latestVersionIndicator":"Yes","beginDate":"2018-05-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-08","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 6/15/18 tt edits per form change.  5/8/18 tt/MA39.","administrativeNotes":"12/12/23 Added alt OID and AQT for CCTG ticket number CADSR0003179 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270948","version":"1","preferredName":"Dose Modification Reason","preferredDefinition":"An explanation for the change or adjustment in the quantity of the agent (such as substance or energy) administered, taken, or absorbed at one time.","longName":"6335551v1.0:6270795v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BB7E28F-258A-5EE7-E053-F662850A0420","latestVersionIndicator":"Yes","beginDate":"2018-05-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-08","modifiedBy":"CLOHNES","dateModified":"2023-10-17","changeNote":"11/26/18 TT released/CWinch. 5/8/18 tt/MA39.","administrativeNotes":"5/31/22 added AQT and alt name OID, CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270951","version":"1","preferredName":"Clinical Study Radiation Therapy Early Discontinue Ind","preferredDefinition":"The indicator as to whether there was an early permanent or temporary, stop or end, to the study radiotherapy.","longName":"RT_DISC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BB89C23-EF83-7D6A-E053-F662850A6BF5","latestVersionIndicator":"Yes","beginDate":"2018-05-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-08","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 6/15/18 tt edits per form changes.  5/8/18 tt/MA39.","administrativeNotes":"12/12/23 Added alt OID and AQT for CCTG ticket number CADSR0003179 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270955","version":"1","preferredName":"Clinical Study Radiation Therapy Early Discontinue Date","preferredDefinition":"The date on which there was an early permanent or temporary, stop or end, to study radiotherapy.","longName":"RT_DISC_DT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BB8C06D-A918-5EE3-E053-F662850A2BA9","latestVersionIndicator":"Yes","beginDate":"2018-05-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-08","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 6/15/18 tt edits per form changes. 5/8/18 tt/MA39.","administrativeNotes":"12/12/23 Added alt OID for CCTG ticket number CADSR0003179 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6272161","version":"1","preferredName":"Adverse Event Related Radiation Therapy Ind","preferredDefinition":"The indicator that asks whether the patient experienced any radiation-related adverse events.","longName":"AE_NA_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BC533FA-E680-53A0-E053-F662850AAF21","latestVersionIndicator":"Yes","beginDate":"2018-05-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-09","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/9/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6272162","version":"1","preferredName":"Person Clinical Trial Protocol Questionnaire Complete Indicator","preferredDefinition":"The indicator related to the completion of clinical trial questionnaire(s).","longName":"QUES_QOL_2","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BC5AD54-B8AB-539A-E053-F662850A62C3","latestVersionIndicator":"Yes","beginDate":"2018-05-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-09","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/29/18 tt associated with new VD.  5/9/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6272169","version":"1","preferredName":"Person Clinical Trial Protocol Questionnaire Additional Report Ind","preferredDefinition":"The indicator that signifies whether or not the individual has an additional questionnaire to report.","longName":"6272166v1.0:3506036v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BC6838B-8AC0-3E44-E053-F662850A5092","latestVersionIndicator":"Yes","beginDate":"2018-05-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-09","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/9/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6272176","version":"1","preferredName":"Clinical Trial Economics Travel Count","preferredDefinition":"Clinical trial economics result for the amount of travel.","longName":"6272175v1.0:5918221v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BC6838B-8B35-3E44-E053-F662850A5092","latestVersionIndicator":"Yes","beginDate":"2018-05-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-09","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt edits/changes to DEC. Created for Trial Specific Economics form. 5/9/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6272189","version":"1","preferredName":"Clinical Trial Economics Travel Distance Unit of Measure","preferredDefinition":"Clinical trial economics standard distance measurement for travel.","longName":"6272175v1.0:6272183v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BC6054A-4684-5395-E053-F662850A0309","latestVersionIndicator":"Yes","beginDate":"2018-05-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-09","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt edits per changes to DEC/VD.  Created for Trial Specific Economics form.  5/9/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6272338","version":"1","preferredName":"Outpatient Visit Occurrence Ind","preferredDefinition":"The indicator for questions related to the instances of outpatient visits.","longName":"OUT_LOG_VISITS_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BDB0268-8FAF-40BC-E053-F662850A2CC2","latestVersionIndicator":"Yes","beginDate":"2018-05-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-10","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt edits/Outpatient Visits Form.  5/10/18 tt/MA39.","administrativeNotes":"12/12/23 Added AQT for CCTG ticket number CADSR0003182 cj; 8/4/2022: fixed the box symbol in AQT_wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6272416","version":"1","preferredName":"Intervention or Procedure Begin Ind","preferredDefinition":"The indicator as to whether an activity that produces an effect, or that is intended to alter the course of a disease in a patient began.","longName":"TX_ST_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BDDE472-A6FB-4A7F-E053-F662850ACAA2","latestVersionIndicator":"Yes","beginDate":"2018-05-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-10","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"5/10/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6272434","version":"1","preferredName":"Lost Productivity Less Than One Month Specify Week Count","preferredDefinition":"Specify the number of weeks for lost productivity less than one month.","longName":"6183615v1.0:6272433v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BE0567E-6756-067D-E053-F662850A0C1E","latestVersionIndicator":"Yes","beginDate":"2018-05-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-10","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/10/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6272435","version":"1","preferredName":"Lost Productivity One To Three Month Specify Week Count","preferredDefinition":"Specify the number of weeks for lost productivity from one to three months.","longName":"6272296v1.0:6272433v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BE0A551-24EC-4A9B-E053-F662850ADB68","latestVersionIndicator":"Yes","beginDate":"2018-05-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-10","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 4/12/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6272436","version":"1","preferredName":"Lost Productivity Greater Than Three Month Specify Count","preferredDefinition":"Specify the number of months for lost productivity greater than three months.","longName":"6183617v1.0:6272433v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BE0B2A8-63DD-4AA8-E053-F662850AAD52","latestVersionIndicator":"Yes","beginDate":"2018-05-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-10","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/10/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6287013","version":"1","preferredName":"Concomitant Agent Administered Name","preferredDefinition":"The name of the pharmaceutical agent other than agent(s) tested in the protocol administered to or used by a subject either prior to or during the study.","longName":"CON_MED_NM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C404EE3-4C2E-68C9-E053-F662850AC98E","latestVersionIndicator":"Yes","beginDate":"2018-05-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-15","modifiedBy":"KUMMEROA","dateModified":"2023-10-31","changeNote":"5/15/18 tt/CE7.","administrativeNotes":"3/8/23 added 2 AQT for CCTG ticket request CADSR0002117 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6303294","version":"1","preferredName":"Clinical Study Negation Randomization Reason","preferredDefinition":"The explanation for why the patient was not randomized to a study.","longName":"RSN_NOT_RAND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CFAF0F0-8693-57FA-E053-F662850AEE84","latestVersionIndicator":"Yes","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeNote":"11/26/18 TT released/CWinch. 5/24/18 tt/MA39.","administrativeNotes":"2023.10.18 AQT added per ticket request CADSR0002976. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6304243","version":"1","preferredName":"Radiation Therapy Interruption Day Count","preferredDefinition":"The number of days during which there is a temporary cessation of radiation therapy.","longName":"6304242v1.0:3285185v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D5748F7-7283-128C-E053-F662850A4C05","latestVersionIndicator":"Yes","beginDate":"2018-05-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-29","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 5/29/18 tt/MA39.","administrativeNotes":"12/12/23 Added alt OID for CCTG ticket number CADSR0003179 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6304245","version":"1","preferredName":"Clinical Study Radiation Therapy Early Discontinue Reason","preferredDefinition":"An explanation for the early permanent or temporary, stop or end, to study radiotherapy.","longName":"RT_DISC_REAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D5748F7-72A5-128C-E053-F662850A4C05","latestVersionIndicator":"Yes","beginDate":"2018-05-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-29","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 6/15/18 tt edits per form changes. 5/29/tt/MA39.","administrativeNotes":"12/12/23 Added alt OID for CCTG ticket number CADSR0003179 cjl. 11/7/23 Added AQT and alt OID for CCTG for ticket number CADSR0003018 cjl; 5/31/22 added AQT and alt name OID, CCTG cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6304258","version":"1","preferredName":"Clinical Trial Defined Administrative Activity Specify","preferredDefinition":"The free text field to define the response for administrative.","longName":"6304257v1.0:5566342v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D5AB26A-EE5F-6869-E053-F662850A5DA0","latestVersionIndicator":"Yes","beginDate":"2018-05-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-29","modifiedBy":"CLOHNES","dateModified":"2023-11-14","changeNote":"11/26/18 TT released/CWinch. 5/29/18 tt/MA39.","administrativeNotes":"11/07/23 Added alt OID for CCTG ticket number CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6304262","version":"1","preferredName":"Investigator Decision Specify","preferredDefinition":"The free text field to define the response for investigator decision.","longName":"6304261v1.0:5566342v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D5780FF-1850-1336-E053-F662850AA596","latestVersionIndicator":"Yes","beginDate":"2018-05-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-29","modifiedBy":"CLOHNES","dateModified":"2023-11-14","changeNote":"11/26/18 TT released/CWinch. 5/29/18 tt/MA39.","administrativeNotes":"11/07/23 Added requested alt OID for CCTG ticket CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6306910","version":"1","preferredName":"Lost Productivity Employment Status","preferredDefinition":"The state of employment status.","longName":"6306909v1.0:6160814v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D6B8366-0732-5B9A-E053-F662850ABB56","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-30","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt/MA39.","administrativeNotes":"7/1/22 added OID, CCTG cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6306969","version":"1","preferredName":"Clinical Trial Economics Parking Cost Assessment Ind","preferredDefinition":"Clinical trial economics indicator for parking costs.","longName":"6306965v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D6BA8BB-348C-5B86-E053-F662850A945D","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-30","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt/MA39 Created for Trial Specific Economics form.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6306974","version":"1","preferredName":"Clinical Trial Economics Parking Cost Assessment Value","preferredDefinition":"Clinical trial economics numerical four digit value for parking costs.","longName":"6306965v1.0:3872712v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D6BA8BB-34B0-5B86-E053-F662850A945D","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-30","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 6/15/18 tt edits to draft new CDE. 5/30/18 tt /MA39.  Created for Trial Specific Economics form.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6306982","version":"1","preferredName":"Clinical Trial Economics Parking Cost Assessment Currency Type","preferredDefinition":"Clinical trial economics official government currency for parking costs.","longName":"6306977v1.0:6306981v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D6ECD49-366A-098A-E053-F662850AD2B8","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-30","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt/MA39.  Created for Trial Specific Economics form.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6306986","version":"1","preferredName":"Clinical Trial Economics Parking Cost Assessment Days Count","preferredDefinition":"Clinical trial economics result for the number of paid parking days.","longName":"6306985v1.0:6272433v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D6BA8BB-34C3-5B86-E053-F662850A945D","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-30","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt/MA39.  Created for Trial Specific Economics form.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6306994","version":"1","preferredName":"Outpatient Visit Intervention or Procedure Occurrence Ind","preferredDefinition":"The indicator for questions related to the instances of outpatient activities that produce an effect, or intended to alter the course of a disease in a patient.","longName":"6306990v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D6FF5D5-13EA-225C-E053-F662850A6986","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-30","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt/MA39; Outpatient Visits Form.","administrativeNotes":"12/12/23 Added AQT for CCTG ticket number CADSR0003182 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6307902","version":"1","preferredName":"Outpatient Patient Visit Occurrence Type","preferredDefinition":"The type of healthcare facility patient visit for diagnosis or treatment without being admitted for an overnight stay.","longName":"OUT_LOG_VIS_D","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D7149F9-4D86-0C52-E053-F662850AFDDC","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-30","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 6/18/18 tt edits/form changes.  5/30/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6308834","version":"1","preferredName":"Outpatient Visit Provider Occupation Type","preferredDefinition":"The occupation of the provider for outpatient visit care.","longName":"PROV_TYP_D","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D7235C4-BC5C-1A1B-E053-F662850A61DC","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-30","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6312468","version":"1","preferredName":"Outpatient Visit Occurrence Count","preferredDefinition":"The number of outpatient visits.","longName":"OUT_VIS_NUM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D7295AE-8AF2-2602-E053-F662850AE595","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-30","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6314261","version":"1","preferredName":"Emergency Room Patient Visit Diagnosis Text","preferredDefinition":"Free text field for the diagnosis from the patient's visit to the ER.","longName":"ER_DIAG","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D729CC6-193F-260D-E053-F662850A2693","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-30","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6316030","version":"1","preferredName":"Outpatient Visit Intervention or Procedure Occurrence Count","preferredDefinition":"The number of instances for outpatient activities that produce an effect, or intended to alter the course of a disease in a patient.","longName":"OUT_LOG_QUAN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D7710DB-7B5B-4CA2-E053-F662850A70FF","latestVersionIndicator":"Yes","beginDate":"2018-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-31","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 5/31/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6316032","version":"1","preferredName":"Outpatient Visit Intervention or Procedure Occurrence Name","preferredDefinition":"The name of the outpatient event intended to alter the course of a disease in a patient, or to produce an effect.","longName":"PROC_TYP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D77CEA1-FCB6-4CB2-E053-F662850AD1F2","latestVersionIndicator":"Yes","beginDate":"2018-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-31","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 5/31/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6316650","version":"1","preferredName":"Patient Hospitalization Ind","preferredDefinition":"The indicator as to whether the patient was hospitalized.","longName":"HOSP_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D81DD1C-9A0C-44D1-E053-F662850A33CA","latestVersionIndicator":"Yes","beginDate":"2018-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-31","modifiedBy":"CLOHNES","dateModified":"2023-12-18","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt/MA39.","administrativeNotes":"12/18/23 Added AQT for CCTG ticket number CADSR0003182 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6316794","version":"1","preferredName":"Hospital Admission From Patient Visit Location Description Type","preferredDefinition":"A description of the visit location from where the patient was admitted to the hospital.","longName":"6316772v1.0:6307896v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D804832-6043-44BA-E053-F662850AD386","latestVersionIndicator":"Yes","beginDate":"2018-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-31","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 5/30/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6318690","version":"1","preferredName":"Disease or Disorder Principal Diagnosis Name","preferredDefinition":"The first or foremost diagnosis in importance for any abnormal condition of the mind or body.","longName":"PRI_DIAG","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D83F317-7B9E-446C-E053-F662850A4A91","latestVersionIndicator":"Yes","beginDate":"2018-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-31","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 5/31/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6318693","version":"1","preferredName":"Disease or Disorder Secondary Diagnosis Name","preferredDefinition":"The abnormal condition of the mind or body derived as a result of a primary condition, of second rank or importance.","longName":"SEC_DIAG","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D77CEA1-FCDB-4CB2-E053-F662850AD1F2","latestVersionIndicator":"Yes","beginDate":"2018-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-31","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 6/18/18 edits/tt. 5/31/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6320568","version":"1","preferredName":"Hospitalization Clinical Study Protocol Intervention or Procedure Relationship Scale","preferredDefinition":"The scale to determine the relationship for hospitalization due to the protocol activity intended to alter the course of a disease, or produce an effect in a patient.","longName":"IN_LOG_REL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D86DA68-8C2D-130F-E053-F662850A93DC","latestVersionIndicator":"Yes","beginDate":"2018-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-31","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 5/31/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6321060","version":"1","preferredName":"Hospitalization Continue Ind","preferredDefinition":"The indicator as to whether the condition of being treated as a patient in a hospital is ongoing.","longName":"HOSP_ CONT_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D875E04-5C80-468B-E053-F662850AB829","latestVersionIndicator":"Yes","beginDate":"2018-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-31","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 6/18/18 edits/tt. 5/31/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6321082","version":"1","preferredName":"Intervention or Procedure Principal Occurrence Name","preferredDefinition":"The first or foremost event in importance that produces an effect, or intended to alter the course of a disease in a patient or population.","longName":"PRI_PROC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D939DA3-902C-507D-E053-F662850A2B4E","latestVersionIndicator":"Yes","beginDate":"2018-06-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 6/18/18 edits/tt. 6/1/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6321083","version":"1","preferredName":"Intervention or Procedure Secondary Occurrence Name","preferredDefinition":"The activity of second rank or importance that produces an effect, or intended to alter the course of a disease in a patient or population.","longName":"SEC_PROC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D93108F-BA4F-5071-E053-F662850AB7F1","latestVersionIndicator":"Yes","beginDate":"2018-06-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 6/18/18 edits/tt. 6/1/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6321084","version":"1","preferredName":"Patient Hospital Admission Location Description Type","preferredDefinition":"A description of where the patient was admitted to the hospital.","longName":"AD_TO","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D93BB73-DC79-5066-E053-F662850A4C1C","latestVersionIndicator":"Yes","beginDate":"2018-06-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 6/1/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6321306","version":"1","preferredName":"Hospital Patient Discharge Location Description Type","preferredDefinition":"The representation of where the patient was discharged from the hospital to.","longName":"DIS_DEST","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D953A08-F5B1-7A0E-E053-F662850A5972","latestVersionIndicator":"Yes","beginDate":"2018-06-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 6/1/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6323730","version":"1","preferredName":"Healthcare Facility Admission Indicator","preferredDefinition":"The indicator to address the admission of someone to a building or organization where healthcare services are provided.","longName":"INSTITUTION_LOG_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D9AE363-A13D-2265-E053-F662850AEDC9","latestVersionIndicator":"Yes","beginDate":"2018-06-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-01","modifiedBy":"CLOHNES","dateModified":"2023-12-18","changeNote":"11/26/18 TT released/CWinch. 6/22/18 edits.  6/15/18 tt edits to draft new CDE. 6/1/18 tt/MA39.","administrativeNotes":"12/18/23 Added AQT for CCTG ticket number CADSR0003182cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6323741","version":"1","preferredName":"Healthcare Facility Admission Type","preferredDefinition":"The type of building or organization where someone is admitted to for health care services.","longName":"INST_TYP_FAC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D9B230F-9E0E-3E8B-E053-F662850A2AB4","latestVersionIndicator":"Yes","beginDate":"2018-06-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"11/26/18 TT released/CWinch. 6/15/18 tt edits to draft new CDE.  6/1/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6333730","version":"1","preferredName":"Person Dominant Hand Anatomic Site","preferredDefinition":"The preferred hand of use for controlled and efficient performance of motor tasks.","longName":"LT_RT_HAND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E5F13B2-C539-1BBA-E053-F662850A0842","latestVersionIndicator":"Yes","beginDate":"2018-06-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-11","modifiedBy":"FORMBUILDER","dateModified":"2019-05-08","changeNote":"11/26/18 TT released/CWinch. 6/11/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6333978","version":"1","preferredName":"Study Radiation Therapy Administered Negation Clinical Trial Protocol Adherence Ind","preferredDefinition":"The indicator as to whether the study radiotherapy was not given by the stated treatment plan or protocol.","longName":"NON_PROT_RT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E7681E7-FFD9-5825-E053-F662850ABF52","latestVersionIndicator":"Yes","beginDate":"2018-06-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-12","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 6/15/18 tt edits per form changes. 6/12/18 t/MA39.","administrativeNotes":"12/12/23 Added alt OID for CCTG ticket number CADSR0003179 cjl; added AQT and added alt name OID, CCTG 5/31/22 cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6334876","version":"1","preferredName":"Clinical Study Radiation Therapy Modification Ind","preferredDefinition":"The indicator as to whether there were any alterations or changes to the study radiotherapy.","longName":"RT_MODS_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E763809-6738-350B-E053-F662850A0BBC","latestVersionIndicator":"Yes","beginDate":"2018-06-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-12","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 6/15/18 tt edits per form change. 6/12/18 tt/MA39.","administrativeNotes":"12/12/23 Added 4 alt OIDs AQT for CCTG ticket number CADSR0003179 cjl; /7/23 Added AQT and alt OID for CCTG for ticket number CADSR0003018 cjl; 11/6/23 Added alt OID, CCTG for ticket number CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6335559","version":"1","preferredName":"Clinical Trial Protocol Treatment Plan Modification Reason","preferredDefinition":"An explanation for the alteration or change to the protocol treatment plan.","longName":"6335558v1.0:6270795v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EA0CD04-2E35-62C5-E053-F662850AA8F6","latestVersionIndicator":"Yes","beginDate":"2018-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-14","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 6/14/18 tt/MA39.","administrativeNotes":"12/12/23 Added alt OID for CCTG ticket number CADSR0003179 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6335619","version":"1","preferredName":"Healthcare Facility Admission Date","preferredDefinition":"The admission date to a building or organization where healthcare services are provided.","longName":"INST_AD_DT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EB0809F-A625-6624-E053-F662850A29CA","latestVersionIndicator":"Yes","beginDate":"2018-06-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-15","modifiedBy":"CLOHNES","dateModified":"2023-12-13","changeNote":"11/26/18 TT released/CWinch. 6/15/18 tt edits to draft new CDE.  6/15/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6335637","version":"1","preferredName":"Healthcare Facility Patient Discharge Date","preferredDefinition":"The release date of a patient from the building or organization where healthcare services are provided.","longName":"INST_DIS_DT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EAF4527-A080-5CF3-E053-F662850A8480","latestVersionIndicator":"Yes","beginDate":"2018-06-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-15","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 6/15/18 tt/MA39.","administrativeNotes":"12/12/23 Added alt OID for CCTG ticket number CADSR0003182 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6336238","version":"1","preferredName":"Breast Radiation Therapy Field Beam Arrangement Technique Type","preferredDefinition":"The technique used in the beam arrangement of the field for radiotherapy to the breast.","longName":"FIELD_ARR","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F0494F1-0F5B-1EB7-E053-F662850AD848","latestVersionIndicator":"Yes","beginDate":"2018-06-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-19","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 6/19/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6336274","version":"1","preferredName":"Radiation Therapy Procedure Technique Type","preferredDefinition":"The technique used in the treatment of a disease by means of exposure of the target or the whole body to radiation that produces an effect, or intended to alter the course of a disease in a patient or population.","longName":"RAD_TECH","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F060EA5-682A-3370-E053-F662850A7405","latestVersionIndicator":"Yes","beginDate":"2018-06-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-19","modifiedBy":"CLOHNES","dateModified":"2023-11-13","changeNote":"11/26/18 TT released/CWinch. 6/20/18 edits/tt.  6/19/18 tt/MA39.","administrativeNotes":"11/13/23 Added AQT and alt OID and 2 PVs for CCTG ticket number CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6336312","version":"1","preferredName":"Lymph Node Radiation Therapy Field Beam Arrangement Technique Type","preferredDefinition":"The technique used in the beam arrangement of the field for radiotherapy to lymph node(s).","longName":"LYM_FIELD_ARR","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F1330DC-4779-7B85-E053-F662850AE9BE","latestVersionIndicator":"Yes","beginDate":"2018-06-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-20","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 5/20/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6336316","version":"1","preferredName":"Boost Radiation Therapy Field Beam Arrangement Technique Type","preferredDefinition":"The technique used in the beam arrangement of the field for supplemental radiation delivered to a specific area of interest, often to the tumor itself.","longName":"BOOST_FIELD","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F1330DC-47B0-7B85-E053-F662850AE9BE","latestVersionIndicator":"Yes","beginDate":"2018-06-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-20","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 6/20/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6336995","version":"1","preferredName":"Radiosurgery Total Brain Volume Receive Value","preferredDefinition":"The numerical quantity measured, or assigned, or computed, constituting the total volume of the brain receiving radiation surgery.","longName":"TOT_VOL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F172BEC-AEB4-73C1-E053-F662850A0D22","latestVersionIndicator":"Yes","beginDate":"2018-06-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-20","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"6/20/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6338169","version":"1","preferredName":"Imaging Procedure Negation Acquisition Protocol Complete Reason","preferredDefinition":"Text to describe the reason imaging was not completed according to the protocol for creating images or image-derived measurements.","longName":"NON_PROT_IMAG_RSN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F27C06A-EEB5-7AAF-E053-F662850A8F2D","latestVersionIndicator":"Yes","beginDate":"2018-06-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-21","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"6/21/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6338210","version":"1","preferredName":"Radiation Therapy Beam Energy Type","preferredDefinition":"The type of external rays of high energy ionizing radiation that are delivered to precise locations within the body during radiotherapy.","longName":"ENRGY_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F2ACE33-D047-465F-E053-F662850AA5B0","latestVersionIndicator":"Yes","beginDate":"2018-06-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-21","modifiedBy":"TSESU","dateModified":"2023-11-27","changeNote":"11/26/18 TT released/CWinch. 6/21/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6338214","version":"1","preferredName":"Radiation Therapy Lung Correction Use Indicator","preferredDefinition":"The indicator as to whether an adjustment to radiation therapy measurements for the effects of increased transmission through lung tissue was employed.","longName":"LU_COR","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F2B0898-8120-4283-E053-F662850A90BB","latestVersionIndicator":"Yes","beginDate":"2018-06-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-21","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 6/21/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6338302","version":"1","preferredName":"Person Clinical Trial Protocol Serious Adverse Event Current Reporting Period Occurrence Indicator","preferredDefinition":"The indicator as to whether a person had a serious adverse event, as defined in the protocol, during this reporting period.","longName":"SAE_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F2AD840-09AC-57A1-E053-F662850A7441","latestVersionIndicator":"Yes","beginDate":"2018-06-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-21","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"11/26/18 TT released/CWinch. 6/21/18 tt/CE7.","administrativeNotes":"12/12/23 Added AQT for CCTG ticket number CADSR0003182 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6341381","version":"1","preferredName":"Patient Hospitalization Reason","preferredDefinition":"An explanation for the condition of being treated as a patient in a hospital.","longName":"HOSP_REAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F3D0587-518A-7FAB-E053-F662850A2C53","latestVersionIndicator":"Yes","beginDate":"2018-06-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-22","modifiedBy":"WINCHC","dateModified":"2022-03-31","changeNote":"6/22/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6341394","version":"1","preferredName":"Intervention or Procedure Negation Begin Reason","preferredDefinition":"An explanation for why the activity that produces an effect, or intended to alter the course of a disease in a patient or population, did not begin.","longName":"NOT_STRT_REAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F3E112E-6D06-2A34-E053-F662850A8835","latestVersionIndicator":"Yes","beginDate":"2018-06-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-22","modifiedBy":"RAGUNATHANU","dateModified":"2023-07-28","changeNote":"6/22/18 tt/CE7.","administrativeNotes":"6/30/22 added alt name OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6341452","version":"1","preferredName":"Other Radiation Therapy Beam Energy Value","preferredDefinition":"The other 2 digit numerical quantity of high energy ionizing radiation that is measured, assigned, or computed for radiotherapy.","longName":"OTH_ENRGY","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F7932C8-8C6D-4DE6-E053-F662850A4A52","latestVersionIndicator":"Yes","beginDate":"2018-06-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-25","modifiedBy":"TSESU","dateModified":"2023-11-27","changeNote":"11/26/18 TT released/CWinch. 6/25/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6341570","version":"1","preferredName":"New Malignant Neoplasm Or Myelodysplastic Syndrome Disease or Disorder Diagnosis Indicator","preferredDefinition":"The indicator for questions to address newly diagnosed cancer or MDS.","longName":"NEW_MALIG_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F7C1351-1F5F-1433-E053-F662850A9C11","latestVersionIndicator":"Yes","beginDate":"2018-06-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-25","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 6/25/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6341815","version":"1","preferredName":"Disease or Disorder Diagnosis Evaluation Method Type","preferredDefinition":"The means, manner of procedure, or systematic course of actions performed in the diagnosis of any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person.","longName":"DX_METH","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F7CD838-6FD1-2F89-E053-F662850A2D13","latestVersionIndicator":"Yes","beginDate":"2018-06-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-25","modifiedBy":"TSESU","dateModified":"2023-11-27","changeNote":"11/26/18 TT released/CWinch. 6/25/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6342961","version":"1","preferredName":"Intravenous Gadolinium Preload Administration Prior To Injection And Magnetic Resonance Imaging Indicator","preferredDefinition":"The indicator to address the IV administration of an additional aliquot of gadolinium before the regular injection and MR imaging.","longName":"GAD_PREL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F8C9136-7BE4-3489-E053-F662850AC375","latestVersionIndicator":"Yes","beginDate":"2018-06-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-26","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"6/26/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6343398","version":"1","preferredName":"New Invasive Primary Malignant Neoplasm Diagnosis Anatomic Site","preferredDefinition":"The named location(s) of or within the body diagnosed with a new invasive primary malignancy.","longName":"6343397v1.0:6230220v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FA29A2F-24C7-2BCF-E053-F662850ACA20","latestVersionIndicator":"Yes","beginDate":"2018-06-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-06-27","modifiedBy":"CLOHNES","dateModified":"2023-01-24","changeNote":"11/26/18 TT released/CWinch. 6/27/18 tt/MA39.","administrativeNotes":"1/24/23 added AQT for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6346014","version":"1","preferredName":"Breast Carcinoma Local-Regional Recurrent Disease Anatomic Site","preferredDefinition":"The named locations of or within the body for the local-regional recurrence of breast cancer.","longName":"RECUR_LOC_SITE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7046A210-55EE-551E-E053-F662850AF903","latestVersionIndicator":"Yes","beginDate":"2018-07-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 7/5/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6346402","version":"1","preferredName":"Breast Carcinoma Distant Recurrent Disease Anatomic Site","preferredDefinition":"The named locations of or within the body for the distant recurrence of breast cancer.","longName":"RECUR_DIST_SITE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"70470C2F-F2A1-3519-E053-F662850AC8DC","latestVersionIndicator":"Yes","beginDate":"2018-07-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-05","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeNote":"11/26/18 TT released/CWinch. 7/5/18 tt/MA39,","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6346958","version":"1","preferredName":"Disease Case Assessment Status","preferredDefinition":"Information related to the case assessment for disease at a particular time.","longName":"DIS_STA_CASE_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"70949475-789C-2EB6-E053-F662850A7D7F","latestVersionIndicator":"Yes","beginDate":"2018-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-09","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"7/9/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6347443","version":"1","preferredName":"Protocol Agent Dose Modification Date","preferredDefinition":"The date on which the quantity of the study agent administered, taken, or absorbed at one time, was modified.","longName":"DOSMOD_DT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"70A4C1EC-9978-28BA-E053-F662850A384E","latestVersionIndicator":"Yes","beginDate":"2018-07-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-10","modifiedBy":"WINCHC","dateModified":"2022-03-14","changeNote":"7/10/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6347446","version":"1","preferredName":"Protocol Agent Dose Modification Type","preferredDefinition":"The kind of modification which was made to the quantity of the study agent administered, taken, or absorbed at one time.","longName":"DOSMOD_TYP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"70A56D91-1DA2-4E2F-E053-F662850AD4BA","latestVersionIndicator":"Yes","beginDate":"2018-07-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-10","modifiedBy":"TSESU","dateModified":"2022-08-18","changeNote":"7/10/18 tt/CE7.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6349280","version":"1","preferredName":"Target Lesion Measurement Unknown Reason","preferredDefinition":"An explanation as to why the measurement of a target lesion (RECIST, etc.) is not known, or not recorded.","longName":"LES_MEAS_UNK_RSN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"70BA7729-3ADE-44F7-E053-F662850A72FA","latestVersionIndicator":"Yes","beginDate":"2018-07-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-11","modifiedBy":"CLOHNES","dateModified":"2023-02-23","changeNote":"7/11/18 tt/CE7.","administrativeNotes":"2/23/23 added AQT for CCTG ticket number CADSR0002081 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6360975","version":"1","preferredName":"Case Report Form Complete Indicator","preferredDefinition":"The indicator as to whether the document designed to record the clinical study-required information on a subject to be reported to the sponsor was completed.","longName":"CRF_COMP_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"714738AA-F655-5651-E053-F662850A0811","latestVersionIndicator":"Yes","beginDate":"2018-07-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-18","modifiedBy":"CLOHNES","dateModified":"2023-11-07","changeNote":"11/26/18 TT released/CWinch. 7/18/18 tt/MA39.","administrativeNotes":"11/7/23 Added alt oid for CCTG for ticket number CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6373841","version":"1","preferredName":"Ongoing Or New Adverse Event Reporting Period Occurrence Indicator","preferredDefinition":"The response to indicate ongoing or new experiences of adverse events for a reporting period.","longName":"AE_OCC_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71DC2E06-8791-31F4-E053-F662850AD7CA","latestVersionIndicator":"Yes","beginDate":"2018-07-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-26","modifiedBy":"HARTLEYG","dateModified":"2021-01-25","changeNote":"11/26/18 TT released/CWinch. 7/26/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6381009","version":"1","preferredName":"Assessment Period Type","preferredDefinition":"The protocol-specific time point when an assessment is to be completed.","longName":"ASSESS_PD_TP_2","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7264CB49-1427-22F1-E053-F662850A201D","latestVersionIndicator":"Yes","beginDate":"2018-08-01","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-08-01","modifiedBy":"CLOHNES","dateModified":"2023-02-23","changeNote":"8/31/17 jk Transferred context, added RECIST CSI and reg status per Round 5 finalization task.  5/25/16 jk added NWU CS/CSI.  8/13/13 added to RECISTv1.1 CRF CSI. jc  6/28/13 added alt question text. jc","administrativeNotes":"2/23/23 added AQT for CCTG ticket number CADSR0002081 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6431974","version":"1","preferredName":"Imaging Technique Negation Acquisition Protocol Complete Modification Reason","preferredDefinition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy._An operation in which a term denies or inverts the meaning of another term or construction._A protocol for creating images or image-derived measurements._To possess every necessary or normal part or component or step; having come or been brought to a conclusion._Modification; the act of making something different._An explanation of the cause of some phenomenon or action.","longName":"6338157v1.0:6431767v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"762B7B35-8F94-1437-E053-F662850AFD7D","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-18","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6438258","version":"1","preferredName":"Treatment Quantity Dose","preferredDefinition":"the measured quantity of an administered therapy._the dose in milligrams.","longName":"2014023v1.0:2432128v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76B75647-9D21-3FA8-E053-F662850A286F","latestVersionIndicator":"Yes","beginDate":"2018-09-25","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-25","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6438262","version":"1","preferredName":"Treatment Quantity Dose","preferredDefinition":"the measured quantity of an administered therapy._the dose in milligrams.","longName":"Daily_Dose_2","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76B75F15-DE23-5C55-E053-F662850A7DBA","latestVersionIndicator":"Yes","beginDate":"2018-09-25","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-25","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6438269","version":"1","preferredName":"Treatment Quantity Dose","preferredDefinition":"the measured quantity of an administered therapy._the dose in milligrams.","longName":"Daily_Dose_3","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76B75647-9D41-3FA8-E053-F662850A286F","latestVersionIndicator":"Yes","beginDate":"2018-09-25","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-25","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6438276","version":"1","preferredName":"Treatment Quantity Dose","preferredDefinition":"the measured quantity of an administered therapy._the dose in milligrams.","longName":"Daily_Dose_4","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76B75F15-DE43-5C55-E053-F662850A7DBA","latestVersionIndicator":"Yes","beginDate":"2018-09-25","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-25","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6438301","version":"1","preferredName":"Treatment Quantity Dose","preferredDefinition":"the measured quantity of an administered therapy._the dose in milligrams.","longName":"Daily_Dose_5","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76B76D19-1F3E-232A-E053-F662850A2FBE","latestVersionIndicator":"Yes","beginDate":"2018-09-25","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-25","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6438302","version":"1","preferredName":"Treatment Quantity Dose","preferredDefinition":"the measured quantity of an administered therapy._the dose in milligrams.","longName":"Daily_Dose_6","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76B72663-DBDE-336A-E053-F662850AF79F","latestVersionIndicator":"Yes","beginDate":"2018-09-25","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-25","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6438303","version":"1","preferredName":"Treatment Quantity Dose","preferredDefinition":"the measured quantity of an administered therapy._the dose in milligrams.","longName":"Daily_Dose_7","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76B76D19-1F4F-232A-E053-F662850A2FBE","latestVersionIndicator":"Yes","beginDate":"2018-09-25","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-25","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6438407","version":"1","preferredName":"Whole Brain Radiation Therapy Administered Type","preferredDefinition":"information related to radiation therapy administered to a patient._Something distinguishable as an identifiable class based on common qualities.","longName":"WBRT_TYP_1","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76C72E8B-3D13-6330-E053-F662850A424C","latestVersionIndicator":"Yes","beginDate":"2018-09-26","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-26","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6466609","version":"1","preferredName":"Device Immobilization Preparation Elapsed Time","preferredDefinition":"Information related to the time required from start of the patient immoblization process for radiotherapy, to the time of completion.","longName":"IMMOBIL_TIME","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"777D6F94-C411-1559-E053-F662850A2CF9","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6466614","version":"1","preferredName":"Magnetic Resonance Imaging Preparation Time","preferredDefinition":"Information relating to the time for the MRI Simulation process. The time from MRI bed preparation to the time completed.","longName":"MRI_SIM_PREP_TIME","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"777CFF41-FA5C-0B26-E053-F662850A235B","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468343","version":"1","preferredName":"Radiation Therapy Therapist Preparation Time","preferredDefinition":"Information relating to time required by therapist for RT delivery.","longName":"TX_THERAPIST_TIME","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"777D818F-7759-4A84-E053-F662850A27FE","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468346","version":"1","preferredName":"Radiation Therapy Preparation Time","preferredDefinition":"Information relating to the time required to set up for RT delivery.","longName":"RT_PREP_TIME","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"777C63FD-D40E-0B21-E053-F662850A38EA","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468353","version":"1","preferredName":"Radiation Therapy Physics Quality Assurance Preparation Time","preferredDefinition":"Information regarding the total time required for physics and quality assurance as part of the RT preparation process.","longName":"RT_QA_PREP_TIME","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"777D6F94-C422-1559-E053-F662850A2CF9","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468354","version":"1","preferredName":"Radiation Therapy Total Preparation Time","preferredDefinition":"Total preparation time for RT delivery","longName":"RT_PREP_TIME_TOTAL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"777E192C-FE4B-0CC7-E053-F662850AC6BB","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468360","version":"1","preferredName":"Radiation Therapy Administration Time","preferredDefinition":"Information relating to the time for RT delivery or administration.","longName":"RT_DELIVERY_TIME","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"777E2AF1-CD8E-0E76-E053-F662850AB4E6","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468361","version":"1","preferredName":"Total Radiation Therapy  Time","preferredDefinition":"Information relating to the total time taken to prepare and administer radiation therapy.","longName":"RT_TIME_TOTAL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"777E2AF1-CDBB-0E76-E053-F662850AB4E6","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468694","version":"1","preferredName":"Radiation Therapy Immobilization Findings Indicator","preferredDefinition":"Indicator for whether or not there were abnormal findings or observations during immobilization process.","longName":"RT_IMMOB_FINDINGS_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"777F882B-89B3-330A-E053-F662850A1788","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468701","version":"1","preferredName":"Radiation Therapy Immobilization Findings Specify","preferredDefinition":"Details of abnormal findings during immobilization process","longName":"RT_IMMOB_FINDINGS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"777F1559-47A8-7CB3-E053-F662850A7F7F","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468705","version":"1","preferredName":"MRI Preparation Findings Indicator","preferredDefinition":"Indicator if abnormal findings were observed during MRI simulation or preparation.","longName":"MRI_PREP_FINDINGS_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7780606B-78F0-53F6-E053-F662850A499E","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468706","version":"1","preferredName":"MRI Preparation Findings Specify","preferredDefinition":"Details of abnormalities or findings observed during MRI simulation process.","longName":"MRI_PREP_FINDINGS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77801E04-C7A6-6ED0-E053-F662850AD630","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468716","version":"1","preferredName":"Radiation Therapy Administration Findings Indicator","preferredDefinition":"Indicator as to whether or not there were abnormal findings during RT delivery.","longName":"RT_DELIVERY_FINDINGS_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7780CF6C-BB9A-2729-E053-F662850A7E07","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468717","version":"1","preferredName":"Radiation Therapy Administration Findings Specify","preferredDefinition":"Details of abnormal findings or observations during delivery of radiation therapy.","longName":"RT_DELIVERY_FINDINGS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7780D7CA-0961-2658-E053-F662850A6E4B","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468730","version":"1","preferredName":"Person Affiliation Role Type","preferredDefinition":"The action or activity assigned to, or required or expected of, a person in a formal association with a group or organization. In this case, referring to involvement in the process of RT delivery","longName":"ROLE_TXT_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77817134-11AF-1CBD-E053-F662850A68DB","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":"Removed from Person SSN CSI 1/7/09 mcooper","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468734","version":"1","preferredName":"Radiation Therapy Staff Participant Indicator","preferredDefinition":"Indicator for staff role involvement with radiation therapy preparation and delivery process","longName":"ROLE_PARTIC_Q","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"778147B1-A01D-74D5-E053-F662850A4B49","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468744","version":"1","preferredName":"Radiation Therapy Process Type","preferredDefinition":"Processes involvement in delivery of radiation therapy.","longName":"RT_PROCESS_TYP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77813105-69E3-75B6-E053-F662850A2809","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468749","version":"1","preferredName":"Radiation Therapy Staff  Number","preferredDefinition":"Number of staff participants involved.","longName":"RT_STAFF_NUMBER","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77817FE1-AC08-1626-E053-F662850A2FAF","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6468753","version":"1","preferredName":"Radiation Therapy Process Time Percentage Value","preferredDefinition":"The percentage of time involved in a particular process","longName":"RT_TIME_PARTIC_PCT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7781D2EF-3487-186D-E053-F662850A4CBF","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-05","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6532331","version":"1","preferredName":"Radiation Therapy Health Economics Information Complete Yes No Indicator","preferredDefinition":"Leading question for health economics assessment.","longName":"6532269v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"789AB1CC-1F27-0FF8-E053-F662850AAB57","latestVersionIndicator":"Yes","beginDate":"2018-10-19","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-10-19","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6813999","version":"1","preferredName":"Laboratory Procedure Oncotype DX Breast Cancer Assay Result Score","preferredDefinition":"the source of an Oncotype DX breast cancer assay, a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Score (0-100).","longName":"LAB_ONCODX_RSL_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D3079F8-F83E-6D15-E053-F662850A5519","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"WINCHC","dateCreated":"2019-07-08","modifiedBy":"WINCHC","dateModified":"2019-11-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6968100","version":"1","preferredName":"New Personal Medical History Yes No Indicator","preferredDefinition":"Having no previous example or precedent or parallel; of a kind not seen before._A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"PT_MEDHX_PRO_IND2","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"NCIC CRF:National Cancer Institute of Canada Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94170246-B94E-0C10-E053-F662850A2DDF","latestVersionIndicator":"Yes","beginDate":"2019-10-04","endDate":null,"createdBy":"WINCHC","dateCreated":"2019-10-04","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"Replaced VD Chronic Disease Ind-2 2179984v1 with VD ID#3506068 - Yes No Indicator   - dbw","administrativeNotes":"12/12/23 Added AQT and alt OID for CCTG ticket number CADSR0003182 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7110056","version":"1","preferredName":"Brain Metastatic Neoplasm Initial Diagnosis Present Yes No Indicator","preferredDefinition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium._A tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site. Metastasis is characteristic of advanced malignancies, but in rare instances can be seen in neoplasms lacking malignant morphology.:The first diagnosis of the individual's condition._Being or existing in a specified place or at the specified time._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"BRAI_CLI_EVI_PRE_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A62235D-0FC6-4B50-E053-F662850A2A5A","latestVersionIndicator":"Yes","beginDate":"2019-12-23","endDate":null,"createdBy":"WINCHC","dateCreated":"2019-12-23","modifiedBy":"KUMMEROA","dateModified":"2023-07-20","changeNote":"Replaced VD Involvement Extent Disease Ind-2 - 2180012v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"2023.7.20 Updated def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7110447","version":"1","preferredName":"Extracranial Metastatic Neoplasm Site Count","preferredDefinition":"Outside of the cranium (bones that surround the brain)._A tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site.  Metastasis is characteristic of advanced malignancies, but in rare instances can be seen in neoplasms lacking malignant morphology._A position in relation to its surroundings._To determine the number or amount of something; the result of this activity._the number or amount of metastatic sites for the patient's stratification determination._The spread of cancer from one part of the body to another. A tumor formed by cells that have spread is called a \"metastatic tumor\" or a \"metastasis.\" The metastatic tumor contains cells that are like those in the original (primary) tumor.","longName":"7110097v1.0:7110225v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A62235D-10A9-4B50-E053-F662850A2A5A","latestVersionIndicator":"Yes","beginDate":"2019-12-23","endDate":null,"createdBy":"WINCHC","dateCreated":"2019-12-23","modifiedBy":"WINCHC","dateModified":"2020-09-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7110536","version":"1","preferredName":"Disease Description Disease Status Type","preferredDefinition":"a description of the patient's cancer._a field to report the current status of the patient's disease.","longName":"DZ_STAT_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A624564-720C-44C5-E053-F662850A93DB","latestVersionIndicator":"Yes","beginDate":"2019-12-23","endDate":null,"createdBy":"WINCHC","dateCreated":"2019-12-23","modifiedBy":"WINCHC","dateModified":"2021-03-04","changeNote":"new version created to allow use by multiple diseases and remove DE duplicate; released.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421798","version":"1","preferredName":"Patient Remote Assessment Indicator","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Far away in distance or space; happening at a distance._The final result of a determination of the value, significance, or extent of._Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"ASSESS_RM_YN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6F47DB-200A-5D56-E053-4EBD850A4FB7","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-09-16","modifiedBy":"WINCHC","dateModified":"2021-01-04","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7421816","version":"1","preferredName":"Remote Assessment Method Type","preferredDefinition":"Far away in distance or space; happening at a distance._The final result of a determination of the value, significance, or extent of._Something distinguishable as an identifiable class based on common qualities._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Far away in distance or space; happening at a distance._The final result of a determination of the value, significance, or extent of._Something distinguishable as an identifiable class based on common qualities.","longName":"ASSESS_METH_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF6EDE2F-6F2A-207D-E053-4EBD850A0345","latestVersionIndicator":"Yes","beginDate":"2020-09-16","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-09-16","modifiedBy":"WINCHC","dateModified":"2021-01-04","changeNote":"ISO 11179 compliance; due to internal error, not shown as most recent version - no other version exists, created new version.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533637","version":"1","preferredName":"Patient New Malignant Neoplasm Diagnosis Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patients meets the eligibility requirements for participation in a clinical trial with regards to newly diagnosed cancer.","longName":"7545530v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6AB0565-AD27-2D4A-E053-4EBD850A93F0","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533649","version":"1","preferredName":"Patient Lymph Node Micrometastasis Post Axillary Lymph Node Dissection Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient meets the eligibility requirements for participation in a clinical trial with regards to lymph node micrometastases after the surgical removal of axillary lymph nodes.","longName":"7545539v1.0:3506036v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6971F7C-FD79-3BCE-E053-4EBD850A783C","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533651","version":"1","preferredName":"Patient Lymph Node Micrometastasis Post Sentinel Lymph Node Biopsy Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient meets the eligibility requirements for participation in a clinical trial with regards to lymph node micrometastases after the surgical removal and examination of the sentinel node.","longName":"7545542v1.0:3506036v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B697979F-8DC4-366C-E053-4EBD850A988B","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533652","version":"1","preferredName":"Patient Hormone Receptor Test Outcome Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient meets the eligibility requirements for participation in a clinical trial with regards to the results of hormone receptor testing.","longName":"7545546v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6AA0579-02FF-6651-E053-4EBD850A39F3","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533657","version":"1","preferredName":"Patient Hormone Therapy Occurrence Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient meets the eligibility requirements for participation in a clinical trial with regards to hormonal treatment(s).","longName":"7545549v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6971896-99B3-382C-E053-4EBD850A179F","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"TAYLORT","dateModified":"2022-02-10","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533664","version":"1","preferredName":"Trial Screening Informed Consent Form Signature Date","preferredDefinition":"The date on which the patient signed the screening informed consent form.","longName":"7545555v1.0:2018550v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B697F15B-7EED-2D60-E053-4EBD850AD04F","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533665","version":"1","preferredName":"Patient Lymph Node Disease Limited To Isolated Tumor Cells Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient meets the eligibility requirements for participation in a clinical trial with regards to nodal disease that is limited to isolated tumour cells.","longName":"7545552v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B697EBF4-C011-3921-E053-4EBD850A943F","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533668","version":"1","preferredName":"Patient pT3N1 Or pT4 Stage Finding Disease Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient meets the eligibility requirements for participation in a clinical trial with regards to pT3N1 or pT4 stage disease.","longName":"7545558v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B697979F-8DFD-366C-E053-4EBD850A988B","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"TSESU","dateModified":"2023-06-02","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7533670","version":"1","preferredName":"Patient Personal Medical History Treated Ipsilateral Breast Disease Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient's medical history meets the eligibility requirements for participation in a clinical trial with regards to treated ipsilateral breast disease.","longName":"7545562v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6AC6B48-2A96-726D-E053-4EBD850AA660","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534122","version":"1","preferredName":"Patient Oncotype DX Breast Recurrence Score Result Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient meets the eligibility requirements for participation in a clinical trial based on the results of the Oncotype DX breast cancer assay","longName":"7545578v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6ADD55E-051A-33BD-E053-4EBD850AE930","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534123","version":"1","preferredName":"Oncotype DX Breast Recurrence Score Result Value","preferredDefinition":"A number between 0-100, based on the results of Oncotype DX breast cancer assay, that assesses the 9-year risk of distant recurrence in node-negative patients, 5-year distant recurrence or mortality in node-positive patients, and the likelihood that chemotherapy will benefit the patient.","longName":"7545612v1.0:7545617v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B687F3D1-01DA-44A5-E053-4EBD850AC064","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"TSESU","dateModified":"2023-06-01","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534126","version":"1","preferredName":"Patient Personal Medical History Axillary Lymph Node Dissection Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient's medical history meets the eligibility requirements for participation in a clinical trial with regards to the surgical removal of axillary lymph nodes.","longName":"7545568v1.0:3506034v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6ADD55E-055D-33BD-E053-4EBD850AE930","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534128","version":"1","preferredName":"Patient Personal Medical History Lymphatic Invasion Clinical Trial Eligibility Criteria Disease Involvement Indicator","preferredDefinition":"An indication whether or not the patient's medical history meets the eligibility requirements for participation in a clinical trial with regards to lymphovascular invasion.","longName":"7545571v1.0:3028355v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B69606DB-9CAF-4A19-E053-4EBD850A9101","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"3/2/21 TL released/CW. MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534139","version":"1","preferredName":"Patient Biospecimen And Tumor Bank Submission Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient's specimen(s) and submission to a tumor bank meet the eligibility requirements for participation in a clinical trial.","longName":"7545581v1.0:3506036v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6972473-269E-3DD5-E053-4EBD850A3CFD","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534141","version":"1","preferredName":"Patient Personal Medical History Adjuvant Chemotherapy Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient's medical history meets the eligibility requirements for participation in a clinical trial with regards to adjuvant chemotherapy.","longName":"7545574v1.0:3506068v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6ADD55E-057D-33BD-E053-4EBD850AE930","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534142","version":"1","preferredName":"Patient Radiation Therapy Prior To Surgical Procedure Occurrence Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient meets the eligibility criteria for participation in a clinical trial with regards to the protocol requirements of radiation therapy before surgery.","longName":"7545584v1.0:3506036v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6A9D136-FD62-7330-E053-4EBD850A2C4C","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534143","version":"1","preferredName":"Patient Radiation Therapy Post Adjuvant Chemotherapy Occurrence Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"An indication whether or not the patient meets the eligibility criteria for participation in a clinical trial with regards to the requirements of radiation therapy after adjuvant chemotherapy.","longName":"7545587v1.0:3506036v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6AF8926-A30B-2F3C-E053-4EBD850A2064","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534144","version":"1","preferredName":"Quality of Life And Arm and Breast Questionnaire Completion Indicator","preferredDefinition":"An indication whether or not the patient meets the eligibility criteria for participation in a clinical trial with regards to the completion of the QOL and Arm and Breast questionnaires.","longName":"7545592v1.0:6005086v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6AF8BC7-0A5F-2F38-E053-4EBD850A1490","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534145","version":"1","preferredName":"Quality of Life And Arm and Breast Questionnaire Completion Date","preferredDefinition":"The date on which the QOL and Arm and Breast questionnaires were completed.","longName":"7545592v1.0:2018550v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6ADE638-1A1D-6084-E053-4EBD850AE785","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"WINCHC","dateModified":"2021-03-05","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534147","version":"1","preferredName":"European Quality of Life Five Dimension Five Level Scale Questionnaire Completion Date","preferredDefinition":"The date on which the EQ-5D questionnaire was completed.","longName":"7545594v1.0:2018550v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6AF93DA-13AA-3228-E053-4EBD850A257F","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"KUMMEROA","dateModified":"2023-11-22","changeNote":"MA39/TL.","administrativeNotes":"2023.11.22 AQT added per ticket request CADSR0003107. ak 11/16/23 Added alt OID and AQT for CCTG ticket number CADSR0003085 cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534150","version":"1","preferredName":"Questionnaire Completion Quality Of Life Exempt Reason","preferredDefinition":"The reason why a person is exempt from completing the questionnaire(s).","longName":"7545045v1.0:6009303v1.0","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6AF9A8B-D5A7-2F3A-E053-4EBD850AF797","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2020-12-17","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeNote":"MA39/TL.","administrativeNotes":"9/26/23 Added AQT and alt OID,CCTG for ticket number CADSR0002884 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8012049","version":"1","preferredName":"Patient Eligibility Yes No Indicator","preferredDefinition":"Indicator of whether or not patient is eligible.","longName":"IE_IEORRES_ELIGSTAT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D61EBB74-D5B2-1EED-E053-4EBD850A296E","latestVersionIndicator":"Yes","beginDate":"2022-01-21","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-01-21","modifiedBy":"CLOHNES","dateModified":"2022-06-09","changeNote":null,"administrativeNotes":"added human readable def (ok per Chad Winch CCTG) released CDE 6/9/22 cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8012050","version":"1","preferredName":"Specimen Submission Correlative Study Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._The act of referring for judgment or consideration by others; the act of handing over something._A type of study that tests for a relationship between a condition and a potential causal factor of the condition._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"IE_IEORRES_SPECSUB","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D61ED25B-C7A9-1EF7-E053-4EBD850A4966","latestVersionIndicator":"Yes","beginDate":"2022-01-21","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-01-21","modifiedBy":"CLOHNES","dateModified":"2022-06-24","changeNote":null,"administrativeNotes":"6/24/22 changed workflow status to released, reg status to application cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8024729","version":"2","preferredName":"Laboratory Data Domain Laboratory Test Original Result Unit Hematology Unit of Measure","preferredDefinition":"The unit of measure for the hematology laboratory original results.","longName":"LB_LBORRESU_HEM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FABBE3C6-01DD-38B8-E053-731AD00A1F98","latestVersionIndicator":"Yes","beginDate":"2022-02-02","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-05-02","modifiedBy":"ZHWENDY","dateModified":"2023-10-13","changeNote":null,"administrativeNotes":"10/13/2023: added a PV per cadsr0002953.wz 5/2/23 Released CDE for CCTG cjl; 5/2/23 Created this V2.0 due to cleanup efforts for the CCTG, added New v2.0 of VD and changed long name to match concepts, added human readable def cjl; 10/5/22 Non-compliant; study is ongoing and AI can not be retired or versioned cjl; 6/22/22 changed workflow status to released non-compliant, reg status to incomplete per quarterly metrics report clean up CJL.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8024743","version":"2","preferredName":"Laboratory Data Domain Laboratory Test Original Result Unit Biochemistry Unit of Measure","preferredDefinition":"The unit of measure for the biochemistry laboratory original results.","longName":"LB_LBORRESU_BIO","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FACBBA7F-D26E-7EA9-E053-731AD00A7A37","latestVersionIndicator":"Yes","beginDate":"2022-02-02","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-05-03","modifiedBy":"CLOHNES","dateModified":"2023-05-03","changeNote":null,"administrativeNotes":"5/3/23 versioned CDE to v2.0 due to VD version., changed long name to match concepts, and added human readable def cjl; due to cleanup efforts for CCTG, C. Winch informed cjl; 10/5/22 Non-compliant; study is ongoing and AI can not be retired or versioned cjl; 6/22/22 changed workflow status to released non-compliant, reg status to incomplete per quarterly metrics report clean up CJL;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8035945","version":"1","preferredName":"Concomitant Medication Dose Unit","preferredDefinition":"The dose unit associated with the concomitant medication taken.","longName":"CM_CMDOSU","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7AD9964-9539-6E05-E053-4EBD850AB134","latestVersionIndicator":"Yes","beginDate":"2022-02-10","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-02-10","modifiedBy":"CLOHNES","dateModified":"2023-02-01","changeNote":null,"administrativeNotes":"6/9/22 added human readable definition, added sys gen def as alt, released CDE cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8037897","version":"1","preferredName":"Bone Marrow Biopsy Dry Tap Procedure Indicator","preferredDefinition":"Indicator of whether or not the bone marrow biopsy procedure resulted in a dry tap.","longName":"SUPPTU_QVAL_DRYTAP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7AE2E1A-B6E3-3448-E053-4EBD850A1501","latestVersionIndicator":"Yes","beginDate":"2022-02-10","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-02-10","modifiedBy":"CLOHNES","dateModified":"2022-06-13","changeNote":"Elevated to Standard per governance approval by RA. 2021-6-10 ak Created as part of the CDISC mapping task_ghd_08.21.18 Released per COG request. mc 5.26.20","administrativeNotes":"6/13/22 Changed long name to reflect concepts, added sys gen def to alt defs, added human readable def, released CDE oked per chad winch CCTG 6/13/22","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8037966","version":"1","preferredName":"Diagnostic Imaging Anatomic Location","preferredDefinition":"The anatomic site name of the diagnostic imaging.","longName":"TU_TULOC_OTHERRAD","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7B10133-3B46-33E3-E053-4EBD850A0A1A","latestVersionIndicator":"Yes","beginDate":"2022-02-10","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-02-10","modifiedBy":"CLOHNES","dateModified":"2022-06-13","changeNote":"** ISO COMPLIANCE ** Lung Change Management 10/07","administrativeNotes":"6/13/22 added sys gen alt def, added human readable def, released CDE per Chad Winch CCTG cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8038384","version":"1","preferredName":"Electrocardiogram ECG Result","preferredDefinition":"Information related to the results of the electrocardiogram.","longName":"EG_EGORRES_ECG","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7C548C4-5231-468E-E053-4EBD850A532B","latestVersionIndicator":"Yes","beginDate":"2022-02-11","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-02-11","modifiedBy":"CLOHNES","dateModified":"2023-02-10","changeNote":"Elevated to Standard per governance approval by RA. 2021-6-9 ak. Created as part of the CDISC mapping task_ghd_08.27.18 Released for COG reuse. 11.5.2020 mc","administrativeNotes":"6/13/22 added system generated def to alt def, added human readable def per Chad Winch CCTG cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8038398","version":"1","preferredName":"Microscopic Examination Hepatitis Serology Performed","preferredDefinition":"An indication whether or not a planned microscopic measurement, test, observation or specimen was performed/collected.","longName":"MI_MIPERF_HBC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7C566F9-1B5A-553C-E053-4EBD850A3AB9","latestVersionIndicator":"Yes","beginDate":"2022-02-11","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-02-11","modifiedBy":"WINCHC","dateModified":"2022-03-07","changeNote":"Elevated to Standard per governance approval by RA. 2021-6-109 ak  Created as part of the CDISC mapping task_ghd_08.21.18 7/20/2021wz: added two alt names per COG request.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8038399","version":"1","preferredName":"Microscopic Examination HIV testing Performed","preferredDefinition":"An indication whether or not a planned microscopic measurement, test, observation or specimen was performed/collected.","longName":"MI_MIPERF_HIV","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7C566F9-1B7C-553C-E053-4EBD850A3AB9","latestVersionIndicator":"Yes","beginDate":"2022-02-11","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-02-11","modifiedBy":"WINCHC","dateModified":"2022-03-07","changeNote":"Elevated to Standard per governance approval by RA. 2021-6-109 ak  Created as part of the CDISC mapping task_ghd_08.21.18 7/20/2021wz: added two alt names per COG request.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8046439","version":"1","preferredName":"Primary Cause of Death Reason Category","preferredDefinition":"Text term that represents the primary cause of death reason category.","longName":"DD_DDORRES_PRCDTH","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83E4EF3-EC80-031B-E053-4EBD850ADC2B","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-02-17","modifiedBy":"CLOHNES","dateModified":"2022-06-08","changeNote":"7/19/17 jk added CSI per Round 5 finalization task.  3/14/17 changed to \"Standard\"; context to NCI Standards per Robinette Renner. 4/27/16 registration set to Proposed per results of COD WG.  12/2/15 corrected typo in question/tt_4/28/15 Released; changed reg status to Qualified. jc  4/7/15 short list of primary COD reasons based on recommendation of the COD Harmonization WG; list is finite - add detailed values to CDE 4783274. jc","administrativeNotes":"added human readable definition, changed long name, released CDE 6/8/22 cjl         \r\nadded AQT and alt name OID, CCTG 6/1/22 cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8074981","version":"1","preferredName":"Tumor Results Domain Bone Marrow Outcome","preferredDefinition":"Information relating to the tumor results from bone marrow.","longName":"TR_TRORRES_BMB_TUMSTATE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9BD9A0D-13A4-22EC-E053-4EBD850AB9C6","latestVersionIndicator":"Yes","beginDate":"2022-03-08","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-03-08","modifiedBy":"CLOHNES","dateModified":"2022-06-09","changeNote":"2/5/20 tmt released/reuse. 2/13/19 Curated to support CDISC Initiative; tmt.","administrativeNotes":"added human readable definition (ok per Chad Winch CCTG), released CDE 6/9/22 cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8083029","version":"1","preferredName":"Protocol Therapy Re-induction Indicator","preferredDefinition":"The act of bringing about something._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Subsequent; immediately following in time or order. An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.__Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"EC_ECOCCUR_REINDUCE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA30263F-B2E5-244C-E053-4EBD850A2467","latestVersionIndicator":"Yes","beginDate":"2022-03-14","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-03-14","modifiedBy":"WINCHC","dateModified":"2022-03-14","changeNote":"Created as part of the CDISC mapping task_ghd_08.21.18 Released per COG request. 9.15.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8131087","version":"1","preferredName":"Procedure Domain Subcategory Blood Transfusion Type","preferredDefinition":"Text term that represents the blood transfusion type.","longName":"PR_PRSCAT_TRAN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB8A4197-11F4-2409-E053-4EBD850A840A","latestVersionIndicator":"Yes","beginDate":"2022-03-31","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-03-31","modifiedBy":"CLOHNES","dateModified":"2022-06-13","changeNote":"Elevated to Standard per governance approval by RA. 2021-6-10 ak 10.26.20 Released for reuse by CTEP CDE Harmonization. mc  2/19/20 tmt transferred ownership from NRDS to NCI Standards/BMaeske and restored CSIs. 11-26-19 tmt removed NCI CSI, associated with NRDS CSI and changed Registration Status. 11-25-19 tmt transferred ownership from NCI Standards to NRDS/BMaeske. Created as part of the CDISC mapping task_ghd_08.24.18","administrativeNotes":"6/13/22 added sys gen def and added human readable def per Chad Winch CCTG cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8137572","version":"1","preferredName":"Case Report Form Additional Loading Yes No Indicator","preferredDefinition":"Indicator of whether or not there is an additional case report form to load.","longName":"TR_TRYN_ADNFRMYN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBD62FB6-39A1-118A-E053-4EBD850ADFED","latestVersionIndicator":"Yes","beginDate":"2022-04-04","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-04","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"5/2/18 tt/CE7.","administrativeNotes":"12/12/23 Added 4 alt OIDs for CCTG ticket CADSR0003182 cjl; 6/10/22 added human readable ok per Chad Winch CCTG cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8137754","version":"2","preferredName":"Disease Response Domain Lesion Overall Response Evaluation Leukemia Type","preferredDefinition":"Text term that represents the overall lesion response evaluation leukemia type.","longName":"RS_RSORRES_OVRLRESP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9115C59-95F8-3B13-E053-731AD00A97F6","latestVersionIndicator":"Yes","beginDate":"2022-04-04","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-04-11","modifiedBy":"CLOHNES","dateModified":"2023-04-11","changeNote":null,"administrativeNotes":"4/11/23 Released CDE for CCTG cjl; 4/11/23 Versioned CDE to 2.0 due to major version of VD (due to max length and rearrangement of long name) and rearrangement of long name and addition of human readable def to CDE cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8137791","version":"1","preferredName":"Clinical Study Additional Information Negation Evaluation Unevaluable Reason","preferredDefinition":"Indicator relating to addition information why a patient is found inevaluable by study chair per protocol._Unable to be evaluated._An explanation of the cause of some phenomenon or action.","longName":"SUPPRS_QVAL_REASNE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBD8F741-8649-34B2-E053-4EBD850AE8FD","latestVersionIndicator":"Yes","beginDate":"2022-04-04","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-04","modifiedBy":"CLOHNES","dateModified":"2023-02-23","changeNote":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8156339","version":"2","preferredName":"Disposition Domain Approval Withdrawl by Subject Indicator","preferredDefinition":"Indicator of whether or not subject gave withdrawl approval.","longName":"SUPPDS_QVAL_APRVLIND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9290898-1EE4-039B-E053-731AD00A57DA","latestVersionIndicator":"Yes","beginDate":"2022-04-11","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-04-12","modifiedBy":"CLOHNES","dateModified":"2023-04-12","changeNote":null,"administrativeNotes":"4/12/23 New version of CDE created - long name changed to order and concepts, human readable def added. Due to cleanup efforts for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8156451","version":"2","preferredName":"Disposition Domain Off Treatment Reason","preferredDefinition":"The reason a person is not receiving therapy and is considered off treatment.","longName":"SUPPDS_QVAL_OPTREAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6C97B06-4958-6683-E053-731AD00A72E2","latestVersionIndicator":"Yes","beginDate":"2022-04-11","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-03-13","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeNote":"Created for CDISC aligned NCI Standard CRF task. mc","administrativeNotes":"3/13/23 versioned CDE to 2.0 due to removal of dup in long name. Also updated definition to a human readable one, retired version 1.0 cjl; 3/7/23 added 1 AQT for CCTG ticket request CADSR0002117 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8160957","version":"1","preferredName":"Patient Neoplasm Personal Medical History Indicator","preferredDefinition":"Indicator of whether or not patient has personal medical history of a neoplasm.","longName":"IE_IEORRES_PRIORMALIG","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC89C0E5-3B57-1932-E053-4EBD850A4CD5","latestVersionIndicator":"Yes","beginDate":"2022-04-13","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-13","modifiedBy":"KUMMEROA","dateModified":"2024-01-30","changeNote":"Replaced VD Assessments Ind-2 2018320v1.0 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"2024.1.29 AQT added per ticket request CADSR0003334. ak 2024.1.10 AQT added per ticket request CADSR0003269. ak 6/22/22 added human readable def, released CDE CJL","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8166868","version":"2","preferredName":"Disease Response Domain Lesion Best Overall Response Evaluation Leukemia Type","preferredDefinition":"Text term that represents the best overall lesion response evaluation leukemia type.","longName":"RS_RSORRES_BESTRESP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F91422E6-63E1-3D17-E053-731AD00AA8D6","latestVersionIndicator":"Yes","beginDate":"2022-04-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-04-11","modifiedBy":"CLOHNES","dateModified":"2023-04-11","changeNote":null,"administrativeNotes":"4/11/23 Versioned CDE to 2.0 due to VD versioned to 2.0, changed long name to reflect concepts, added human readable def due to cleanup activity for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8167561","version":"2","preferredName":"Patient Human Immunodeficiency Virus Infectious Disorder Current Effective Antiretroviral Therapy With Undetectable Viral Load Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"Indicator of whether of not patient with known Human Immunodeficiency Virus taking effective anti-retroviral therapy has an undetectable viral load.","longName":"IE_IEORRES_HIV","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F923C7F0-72B3-05E0-E053-731AD00AA89F","latestVersionIndicator":"Yes","beginDate":"2022-04-14","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-04-12","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeNote":null,"administrativeNotes":"4/12/23 Created v. 2.0 of this CDE due to changing long name of CDE to reflect concepts used, added human readable def for CCTG. Done during cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8174841","version":"1","preferredName":"Head and Neck Neoplasm Eligibility Criteria Yes No Indicator","preferredDefinition":"The response that indicates the patient meets the eligibility requirements for participation in a clinical trial with regards to head and neck neoplasm.","longName":"IE_IEORRES_CANCERDX","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD30D7BB-5EA0-3AD6-E053-4EBD850A044B","latestVersionIndicator":"Yes","beginDate":"2022-04-21","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-21","modifiedBy":"CLOHNES","dateModified":"2022-06-22","changeNote":null,"administrativeNotes":"6/22/22 Added human readable def and released CDE cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8174862","version":"1","preferredName":"Squamous Cell Carcinoma Assessment Yes No Indicator","preferredDefinition":"The Yes or No indicator of the assessment of whether the patient has a carcinoma arising from squamous epithelial cells, and that has undergone a complete excision with no residual disease.","longName":"IE_IEORRES_SQUAMOUS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD2BBDA0-643A-0AE6-E053-4EBD850ACFCA","latestVersionIndicator":"Yes","beginDate":"2022-04-21","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-21","modifiedBy":"WINCHC","dateModified":"2022-04-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8176749","version":"1","preferredName":"Reason Inevaluable Best Overall Response","preferredDefinition":"Indicator relating to addition information why a patient is found inevaluable by study chair per protocol._An explanation of the cause of some phenomenon or action._The most clinically favorable response recorded from the start of the study treatment until the end of treatment._Unable to be evaluated.","longName":"SUPPRS_QVAL_BRREASNE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD914582-8FC2-6AEA-E053-4EBD850A21B7","latestVersionIndicator":"Yes","beginDate":"2022-04-26","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-26","modifiedBy":"WINCHC","dateModified":"2022-04-26","changeNote":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8176751","version":"1","preferredName":"Reason Inevaluable MRD Status","preferredDefinition":"Indicator relating to addition information why a patient is found inevaluable by study chair per protocol._An explanation of the cause of some phenomenon or action._The most clinically favorable response recorded from the start of the study treatment until the end of treatment._Unable to be evaluated.","longName":"SUPPRS_QVAL_MRDREASNE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD9157AB-BC37-762E-E053-4EBD850AC217","latestVersionIndicator":"Yes","beginDate":"2022-04-26","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-26","modifiedBy":"WINCHC","dateModified":"2022-04-26","changeNote":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177025","version":"1","preferredName":"Leukemia Type of Relapse","preferredDefinition":"The characterization of the type of disease relapse (return of signs and symptoms of cancer after a period of improvement) experienced. The basis for the relapse decision.","longName":"SUPPRS_QVAL_RPDTYP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD941BB2-6092-5659-E053-4EBD850A4989","latestVersionIndicator":"Yes","beginDate":"2022-04-26","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-26","modifiedBy":"WINCHC","dateModified":"2022-04-27","changeNote":"Released. AK 2020-6-17; Created for CDSIC aligned NCI Standard CRFs. ghd CDE versioned to change short name from RSGRETP to PRGRCNT per TESTCD naming convention decision. mc 5.14.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177031","version":"1","preferredName":"Secondary Progressive Disease or Recurrent Disease Evaluation Date","preferredDefinition":"The date progressive disease or recurrent disease was identified, represented in an unambiguous date format (e.g., DD-MON-YYYY).","longName":"RS_RSDAT_SECONDRPD","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD952337-069E-7CD3-E053-4EBD850A80D1","latestVersionIndicator":"Yes","beginDate":"2022-04-26","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-26","modifiedBy":"WINCHC","dateModified":"2022-04-26","changeNote":"Released. AK 2020-6-17; Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177109","version":"1","preferredName":"Disposition Domain Clinical Trial Ineligibility Reason","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition._A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes._The state or quality of being disqualified by law, rule, or provision._An explanation of the cause of some phenomenon or action._An explanation of the cause of some phenomenon or action._The state or quality of being disqualified by law, rule, or provision.","longName":"SUPPDS_QVAL_RSFAIL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD94AB89-E0D0-7D89-E053-4EBD850A1CC4","latestVersionIndicator":"Yes","beginDate":"2022-04-26","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-26","modifiedBy":"CLOHNES","dateModified":"2023-02-10","changeNote":"Created for CDISC aligned NCI Standard CRF task. ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177627","version":"1","preferredName":"Tumor Extranodal Extension Evidence of Disease type","preferredDefinition":"information related to extranodal tumor extension._Situated outside of a node._Knowledge on which to base belief._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"SUPPMH_QVAL_XNODEXTN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA81BDA-C6A2-2C36-E053-4EBD850A6271","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-27","modifiedBy":"WINCHC","dateModified":"2022-04-27","changeNote":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177837","version":"1","preferredName":"Nodal Involvement Extent of Nodal Disease","preferredDefinition":"A domain that represents the data that uniquely identifies tumors._Of or pertaining to a node, any bulge or swelling of an anatomical structure or part._To have a connection by participation or association or use; sharing in an activity or process._Of or pertaining to a node, any bulge or swelling of an anatomical structure or part._The range, magnitude, or distance over which a thing spans an interval of distance, space, or time._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"SUPPMH_QVAL_NODAL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA81BDA-C6EF-2C36-E053-4EBD850A6271","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-27","modifiedBy":"WINCHC","dateModified":"2022-04-27","changeNote":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8177862","version":"1","preferredName":"Head and Neck Neoplasm Stage Grouping Stage Category Extent Disease or Disorder Stage","preferredDefinition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body._A grouping of items based on some commonality or by user defined characteristics._The range, magnitude, or distance over which a thing spans an interval of distance, space, or time._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"SUPPRS_QVAL_STAGECAT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA7A215-293C-2C6E-E053-4EBD850A833A","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-27","modifiedBy":"CLOHNES","dateModified":"2023-02-10","changeNote":"6/29/21 TL released.; AK created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8178002","version":"1","preferredName":"Head and Neck Tumor Clinical M Stage","preferredDefinition":"information related to the clinical M stage of a head and neck tumor._The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor._For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"RS_RSORRES_AJCC103","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDB7C7CE-B664-716A-E053-4EBD850ADC84","latestVersionIndicator":"Yes","beginDate":"2022-04-28","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-28","modifiedBy":"WINCHC","dateModified":"2022-04-28","changeNote":"6/29/21 TL released.; AK created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8178096","version":"1","preferredName":"Baseline QOL Complete Form Indicator","preferredDefinition":"The indicator as to whether the patient completed the baseline quality of life form.","longName":"IE_IEORRES_QOL_XQ","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDBA03CE-7DA9-7074-E053-4EBD850AD602","latestVersionIndicator":"Yes","beginDate":"2022-04-28","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-28","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeNote":"10/17/17 tt CE7.","administrativeNotes":"11/16/23 Added alt OID and AQT for CCTG ticket number CADSR0003085 cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8178243","version":"1","preferredName":"Patient Quality of Life Consent Indicator Yes No Exempt","preferredDefinition":"information related to a person who receives medical attention, care, or treatment, giving permission for questions concerning Quality of Life._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied._Immunity from an obligation or duty._Permission to do something.","longName":"IE_IEORRES_HEALTHIND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDBBAD55-00E9-3F84-E053-4EBD850A82B4","latestVersionIndicator":"Yes","beginDate":"2022-04-28","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-28","modifiedBy":"TSESU","dateModified":"2023-01-23","changeNote":"Replaced VD Patient Consent Ind-2 2018303v1.0 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8178406","version":"1","preferredName":"Quality of Life Complete Assessment Yes No Not Required Indicator","preferredDefinition":"information related to the the completion of a quality of life evaluation, an assessment of the overall condition of a human life._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"QS_QSPERF","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDBD8297-F6FC-74BD-E053-4EBD850A6A91","latestVersionIndicator":"Yes","beginDate":"2022-04-28","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-28","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeNote":"Replaced VD Quality of Life Ind-2 2018322v1.0 with VD ID#3506068 - Yes No Indicator   - dbw","administrativeNotes":"2023.11.22 Alt SNs added per ticket request CADSR0003109. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8178455","version":"1","preferredName":"Procedure Domain Not-Done Reason Not Done Intervention or Procedure Reason","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._The explanation given as to why an action was not completed._Indicates a task, process or examination that has either not been initiated or not been completed._An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects._An explanation of the cause of some phenomenon or action.","longName":"PR_PRREASND_VIDEOFS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDC12899-5B8C-6CA5-E053-4EBD850A8696","latestVersionIndicator":"Yes","beginDate":"2022-04-28","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-28","modifiedBy":"MMADDINENI","dateModified":"2024-01-24","changeNote":"Elevated to Standard per governance approval by RA. 2021-6-10 ak Created as part of the CDISC mapping task_ghd_08.27.18 Released for COG reuse. mc 11.12.20 7/202021wz: added one alt name per COG request.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8178608","version":"1","preferredName":"Subject Status Domain Subject Status Original Result Survival Status","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject status._The outcome of the subject status assessment as originally received or collected._Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival._A condition or state at a particular time.","longName":"SS_SSORRES","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDCCA9B0-6F2C-263C-E053-4EBD850AC5A9","latestVersionIndicator":"Yes","beginDate":"2022-04-29","endDate":null,"createdBy":"WINCHC","dateCreated":"2022-04-29","modifiedBy":"WINCHC","dateModified":"2022-04-29","changeNote":"2/13/19 Curated to support CDISC Initiative; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10358385","version":"1","preferredName":"Person Difficulty Speaking Due to Dryness of Mouth and Tongue Assessment Score","preferredDefinition":"A person's stated response of whether they experienced difficulty in speaking due to dryness of mouth and tongue.","longName":"DFC_SPK_DRY_MOU_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-1831-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10358386","version":"1","preferredName":"Person Difficulty Chewing Food Due to Dryness of Mouth Assessment Score","preferredDefinition":"A person's stated response of whether they experienced  difficulty in chewing food due to dryness of mouth.","longName":"DFC_CHEW_DRY_MOU_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-3138-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10358387","version":"1","preferredName":"Person Difficulty Swallowing Food Due to Dryness of Mouth Assessment Score","preferredDefinition":"A person's stated response of whether they experienced difficulty in swallowing food due to dryness of mouth.","longName":"DFC_SW_FD_DRY_MOU_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-313A-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10358388","version":"1","preferredName":"Person Dryness of Mouth when Eating a Meal Assessment Score","preferredDefinition":"A person's stated response of the dryness their mouth feels when eating a meal.","longName":"PRS_DRY_MOU_FLS_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-313C-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10358389","version":"1","preferredName":"Person Dryness of Mouth When Not Eating or Chewing Assessment Score","preferredDefinition":"A person's stated response of the dryness of their mouth while not eating or chewing.","longName":"PRS_DRY_MOU_NT_EAT_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-313E-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10358390","version":"1","preferredName":"Person Frequency of Sipping Liquids to Aid Swallowing Food Due to Dryness of Mouth Assessment Score","preferredDefinition":"A person's stated response of the frequency they sip liquids to aid in swallowing food due to dryness of mouth.","longName":"SP_FL_EAT_DRY_MOU_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-3140-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10358391","version":"1","preferredName":"Person Frequency of Fluid Intake Required for Oral Comfort When Not Eating Due to Dryness of Mouth Assessment Score","preferredDefinition":"A person's stated response of the frequency of fluid intake required for oral comfort when not eating due to dryness of mouth.","longName":"FLD_IN_CMFT_DY_MT_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-3142-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10358392","version":"1","preferredName":"Person Frequency of Sleeping Problems Due to Dryness of Mouth Assessment Score","preferredDefinition":"A person's stated response of the frequency of sleeping problems due to dryness of mouth.","longName":"FQY_SLP_ISS_DR_MT_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-3144-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"CLOHNES","dateModified":"2023-10-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10360304","version":"1","preferredName":"Person During Past Year Satisfied with Family's Financial Situation Assessment Satisfaction Scale","preferredDefinition":"A person's stated observation of  during the past year if they were satisfied with their family's financial situation.","longName":"PRSN_SATD_FAM_FNCL_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-316B-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"CLOHNES","dateModified":"2023-10-19","changeNote":null,"administrativeNotes":"10/19/23 Added 5 concepts to 5 VM with no associated concepts previously per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10360305","version":"1","preferredName":"Person During Past Year Worried About Family's Financial Situation Worry Scale","preferredDefinition":"A person's stated observation of during the past year if they were worried about their family's financial situation.","longName":"PRSN_WRY_FAM_FNCL_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-316D-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10360306","version":"1","preferredName":"Person Perception of Family's Financial Situation Compared to Others of Same Age Scale","preferredDefinition":"A person's stated perception of their family's financial situation compared to others of the same age.","longName":"PRSN_PRCV_FNCL_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-316F-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10360309","version":"1","preferredName":"Person During Past Year Able to Pay for Daily Food Expenses Scale","preferredDefinition":"A person's stated observation of during the past year if they were able to pay for their daily food expenses.","longName":"PRSN_PAY_DLY_FD_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-3173-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10360648","version":"1","preferredName":"Person During Past Year Able to Pay for Daily Housing Expenses Scale","preferredDefinition":"A person's stated observation of during the past year if they able to pay for their daily housing expenses.","longName":"PRSN_PAY_DLY_HS_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-32C7-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10360649","version":"1","preferredName":"Person During Past Year Have to Borrow Money to Help with Treatment-Related Expenses Yes No Indicator","preferredDefinition":"A person's stated observation of whether during the past year they had to borrow money to help with treatment related expenses.","longName":"PRSN_BRO_MN_EXP_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-32C9-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10360652","version":"1","preferredName":"Person Had to Permanently Quit Previous Occupation Because of Cancer Diagnosis and/or Treatment Yes No Indicator","preferredDefinition":"A person's stated observation of whether they had to permanently quit their previous occupation because of cancer diagnosis and/or treatment.","longName":"PRS_QT_WK_CA_DX_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-1833-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10360829","version":"1","preferredName":"Person Family or Friends Had to Permanently Quit Their Job to Help with My Care Needs Because of My Cancer Diagnosis or Treatment Yes No Indicator","preferredDefinition":"A person's stated observation of whether family or friends had to permanently quit their job to help with their care needs because of cancer diagnosis or treatment.","longName":"PSN_FM_QT_WK_HLP_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-32CE-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10360921","version":"1","preferredName":"Person During Past Year Able to Pay for Medications Related to My Treatment Scale","preferredDefinition":"A person's stated observation of during the past year if they were able to pay for medications related to their treatment.","longName":"PRSN_PAY_MEDS_SC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC126EB-FC76-3073-E053-731AD00A1C5A","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10368852","version":"1","preferredName":"Work Due To Medical Appointment Missed Yes No Indicator","preferredDefinition":"Indicator of whether or not work was missed due to a medical appointment.","longName":"WRK_MIS_MD_APPT_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-1DDF-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-05-25","modifiedBy":"CLOHNES","dateModified":"2022-05-31","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10368877","version":"1","preferredName":"Work Due To Medical Appointment Missed Hour Number","preferredDefinition":"Number of work hours missed due to a medical appointment.","longName":"WRK_MIS_MD_APPT_NUM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-1851-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-05-25","modifiedBy":"CLOHNES","dateModified":"2022-05-31","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10373228","version":"1","preferredName":"Person Unable to Perform Usual Activities Lost Productivity Missed Category","preferredDefinition":"A person's stated response, days or hours,  whether they were unable to work or do normal household activities.","longName":"PRS_UNABL_WOK_DAY_HR","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-9413-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-05-26","modifiedBy":"CLOHNES","dateModified":"2022-07-13","changeNote":null,"administrativeNotes":"7/1/22 alt OID, CCTG added cjl; 7/13/22 added AQT for CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10376421","version":"1","preferredName":"Person Average Physical Activity Level Assessment Score","preferredDefinition":"A person's stated response of their average physical activity level.","longName":"PRS_AVG_ACTV_LVL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-21DB-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-05-26","modifiedBy":"ZHWENDY","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10376422","version":"1","preferredName":"Paid Caregiver Assistance Request Lost Productivity Missed Category","preferredDefinition":"Information related to a person's need, days or hours, for a paid caregiver or assistant.","longName":"PAY_CARE_ASIST_ND_TM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-21DD-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-05-26","modifiedBy":"ZHWENDY","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10376427","version":"1","preferredName":"Paid Caregiver Assistance Visit Number Count","preferredDefinition":"Number of paid caregiver or assistant visit times.","longName":"PAY_CRE_ASIS_VIST_NM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-1A86-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-05-26","modifiedBy":"ZHWENDY","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10376429","version":"1","preferredName":"Paid Other Caregiver Assistance Request Lost Productivity Missed Category","preferredDefinition":"Information related to a person's need, days or hours, for other paid caregivers or assistants.","longName":"PAY_OTH_ASIST_ND_TM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-1A89-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-05-26","modifiedBy":"ZHWENDY","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10376430","version":"1","preferredName":"Paid Other Caregiver Assistance Request Other Specify","preferredDefinition":"The free text field that describes the type of other caregivers or assistants.","longName":"PAY_OTH_ASIST_SPE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-1A8B-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-05-26","modifiedBy":"ZHWENDY","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10376431","version":"1","preferredName":"Primary Unpaid Caregiver Relationship Type","preferredDefinition":"Information related to the relationship between the primary unpaid caregiver or assistant and the patient.","longName":"PRMY_UNPAY_ASIST_REL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-1A8D-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-05-26","modifiedBy":"ZHWENDY","dateModified":"2022-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10376432","version":"1","preferredName":"Unpaid Caregiver Assistance Lost Productivity Missed Category","preferredDefinition":"Information related to an unpaid caregiver's or assistant's help in days or hours.","longName":"UNPAY_CARE_ASIST_TM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-21E1-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-05-26","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":null,"administrativeNotes":"7/1/22 added OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10376434","version":"1","preferredName":"Unpaid Caregiver Attend Paid Job Missing Lost Productivity Missed Category","preferredDefinition":"Information related to an unpaid caregiver missed work, days or hours from their paid job.","longName":"UNPAY_CRE_MIS_WOK_TM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-21E4-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-05-26","modifiedBy":"CLOHNES","dateModified":"2023-10-19","changeNote":null,"administrativeNotes":"7/1/22 added alt OID, CCTG cjl;.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10376452","version":"1","preferredName":"Pay Due To Missed Work Hour Affected Type","preferredDefinition":"Text term that represents whether missed work affected pay.","longName":"PAY_AFF_MIS_WRK_HR_TYP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-21E8-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-05-26","modifiedBy":"CLOHNES","dateModified":"2022-05-31","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10376491","version":"1","preferredName":"Estimated Total Appointment Hour Minute Time","preferredDefinition":"Text term that represents the total estimated appointment time spent.","longName":"TOT_EST_APPT_TIM_VAL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-1AAE-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-05-26","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":null,"administrativeNotes":"7/1/22 added alt OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10380334","version":"1","preferredName":"Travel Estimate Distance Kilometer Count","preferredDefinition":"Numeric value to represent the amount of kilometers traveled.","longName":"TRV_EST_DIS_KIL_CNT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-950C-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-05-26","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":null,"administrativeNotes":"7/1/22 alt OID, CCTG added cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10380338","version":"1","preferredName":"Parking Cost Value","preferredDefinition":"Numeric value to represent the amount of money spent for parking.","longName":"PRK_CST_VAL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-951A-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-05-26","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":null,"administrativeNotes":"7/1/22 added alt OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10380339","version":"1","preferredName":"Taxi Service Cost Value","preferredDefinition":"Numeric value to represent the amount of money spent for taxi service.","longName":"TXI_CST_VAL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-951F-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-05-26","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":null,"administrativeNotes":"7/1/22 added alt OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10380345","version":"1","preferredName":"Public Transportation Cost Value","preferredDefinition":"Numeric value to represent the amount of money spent for public transportation.","longName":"PUB_TRNS_CST_VAL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-2216-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-05-26","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":null,"administrativeNotes":"7/1/22 added alt OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10380346","version":"1","preferredName":"Babysitter Cost Value","preferredDefinition":"Numeric value to represent the amount of money spent for babysitter.","longName":"BST_CST_VAL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-2219-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-05-26","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":null,"administrativeNotes":"7/1/22 added alt OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10380828","version":"1","preferredName":"Specify Other Cost Value","preferredDefinition":"Numeric value to represent the amount of money spent for other specified expenses.","longName":"SPY_OTH_CST_VAL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-953E-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-05-26","modifiedBy":"CLOHNES","dateModified":"2022-07-01","changeNote":null,"administrativeNotes":"7/1/22 added alt OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10380829","version":"1","preferredName":"Other Cost Value","preferredDefinition":"Numeric value to represent the amount of money spent for other expenses.","longName":"OTH_CST_VAL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-1D25-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-05-26","modifiedBy":"CLOHNES","dateModified":"2022-05-31","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10422402","version":"1","preferredName":"Assessment Performed Negation Begin Reason","preferredDefinition":"Text used to describe the reason why assessment was not performed.","longName":"AST_PER_NEG_BEG_RSN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC35FEF-33BD-2FB4-E053-731AD00A3999","latestVersionIndicator":"Yes","beginDate":"2022-06-06","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-06-06","modifiedBy":"CLOHNES","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":"Released CDE 6/8/22 cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10422439","version":"1","preferredName":"RT Fractions Weekly Count","preferredDefinition":"Numeric value used to describe the number of RT fractions per week.","longName":"RT_FRT_WKY_CNT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFDCA1E9-3559-2FB2-E053-731AD00A0138","latestVersionIndicator":"Yes","beginDate":"2022-06-06","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-06-06","modifiedBy":"CLOHNES","dateModified":"2022-06-08","changeNote":null,"administrativeNotes":"Released CDE 6/8/22 cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10424930","version":"1","preferredName":"Link Group ID","preferredDefinition":"Identifier used to link multiple tumor results records to a single finding.","longName":"TR_TRLNKGRP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0CF7FDC-A2EF-2FB0-E053-731AD00A00D0","latestVersionIndicator":"Yes","beginDate":"2022-06-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-07","modifiedBy":"MMADDINENI","dateModified":"2022-08-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10425480","version":"1","preferredName":"Disease not assessed per protocol reason specify reason indicator","preferredDefinition":"An indicator to specify reason disease response not assessed per protocol.","longName":"SUPPRS_QVAL_REASDNAP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-670A-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-07","modifiedBy":"MMADDINENI","dateModified":"2022-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10453927","version":"1","preferredName":"Link Group ID","preferredDefinition":"An identifier used to link multiple tumor identification records to a single finding.","longName":"TU_TULNKGRP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-78A4-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-09","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-09","modifiedBy":"MMADDINENI","dateModified":"2022-08-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10496127","version":"1","preferredName":"Contralateral Disease Present Indicator","preferredDefinition":"Indicator of whether or not contralateral disease is present.","longName":"CON_DZ_PRES_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E1816FA4-E67D-496D-E053-731AD00A66B6","latestVersionIndicator":"Yes","beginDate":"2022-06-21","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-06-21","modifiedBy":"CLOHNES","dateModified":"2022-06-23","changeNote":null,"administrativeNotes":"6/21/22 created CDE, added 3 AQTs, added 3 OID, CCTG for Chad Winch cjl; 6/23/22 released CDE cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10558866","version":"1","preferredName":"Procedure Agents Domain Not-Done Administration Reason","preferredDefinition":"Text used to describe the reason why a procedure agent was not administered.","longName":"PR_AG_DM_NT_DN_AD_RS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26FF5FD-9AA8-66FB-E053-731AD00AB816","latestVersionIndicator":"Yes","beginDate":"2022-07-06","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-07-06","modifiedBy":"CLOHNES","dateModified":"2022-07-08","changeNote":null,"administrativeNotes":"7/6/22 added AQT and alt OID, CCTG for Chad Winch CCTG cjl; 7/8/22 Released CDE for CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10559062","version":"1","preferredName":"Primary Tumor Location Head and Neck Carcinoma Subsite Name","preferredDefinition":"Text term used to represent the subsite name of primary tumor location of the head and neck carcinoma.","longName":"P_TM_LC_H_N_CA_SB_NM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26FF5FD-9AE5-66FB-E053-731AD00AB816","latestVersionIndicator":"Yes","beginDate":"2022-07-06","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-07-06","modifiedBy":"CLOHNES","dateModified":"2022-08-03","changeNote":null,"administrativeNotes":"8/3/22 added AQT for Chad Winch CCTG cjl; 8/3/22 added alt OID, CCTG for Chad Winch CCTG cjl; 7/8/22 Released CDE for CCTG cjl; 7/6/22 added AQT and alt OID, CCTG for Chad Winch CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10559214","version":"1","preferredName":"Procedure Agents Domain Intervention Injection Site Count","preferredDefinition":"Numeric value used to describe the number of procedure agent injection sites.","longName":"PRC_AGT_DM_INJ_ST_CT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26FF5FD-9B2C-66FB-E053-731AD00AB816","latestVersionIndicator":"Yes","beginDate":"2022-07-06","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-07-06","modifiedBy":"CLOHNES","dateModified":"2022-07-08","changeNote":null,"administrativeNotes":"7/8/22 Released CDE for CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10559353","version":"1","preferredName":"Anesthesia Procedure Injection Method of Administration Type","preferredDefinition":"Text term that represents the anesthesia procedure injection method of administration type.","longName":"AN_PR_IN_MT_ADM_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E318AE6A-3D44-66F7-E053-731AD00A35C4","latestVersionIndicator":"Yes","beginDate":"2022-07-06","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-07-06","modifiedBy":"CLOHNES","dateModified":"2023-04-06","changeNote":null,"administrativeNotes":"7/8/22 Released CDE for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10563132","version":"1","preferredName":"Lost Productivity Occurrence Hour Number","preferredDefinition":"A number that identifies how many hours of lost productivity occurred.","longName":"LT_PRD_OCC_HR_CT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E33AB560-95BA-7847-E053-731AD00AE164","latestVersionIndicator":"Yes","beginDate":"2022-07-07","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-07-07","modifiedBy":"CLOHNES","dateModified":"2022-07-28","changeNote":null,"administrativeNotes":"7/13/22 released CDE for CCTG per Chad Winch cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10563133","version":"1","preferredName":"Lost Productivity Occurrence Day Number","preferredDefinition":"A number that identifies how many days of lost productivity occurred.","longName":"LT_PRD_OCC_D_CT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E33B0D39-E4F1-025F-E053-731AD00A90EF","latestVersionIndicator":"Yes","beginDate":"2022-07-07","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-07-07","modifiedBy":"CLOHNES","dateModified":"2022-07-28","changeNote":null,"administrativeNotes":"7/13/22 released CDE for CCTG per Chad Winch cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10598831","version":"1","preferredName":"EQ-5D-5L Questionnaire Consent Yes No Exempt","preferredDefinition":"Indicator of whether EQ-5D has been completed for patient, and patient has consented to future assessments.","longName":"EQ5D5L_CNSNT_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3CA5996-043F-27DB-E053-731AD00A3CAC","latestVersionIndicator":"Yes","beginDate":"2022-07-14","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-14","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeNote":"Replaced VD Patient Consent Ind-2 2018303v1.0 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"11/16/23 Added alt OID and AQT for CCTG ticket number CADSR0003085 cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10599788","version":"1","preferredName":"Patient Health-related Quality of Life Consent Exempt Reason","preferredDefinition":"The reason a patient is exempt from completing the FIT quality of life questionnaire.","longName":"FIT_EXEM_RSN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3CAAEE6-0418-31B5-E053-731AD00AED10","latestVersionIndicator":"Yes","beginDate":"2022-07-14","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-14","modifiedBy":"TSESU","dateModified":"2022-09-06","changeNote":"MA39/TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10599789","version":"1","preferredName":"EQ-5D Questionnaire Consent Exempt Reason","preferredDefinition":"The reason a patient is exempt from completing the EQ-5D quality of life questionnaire.","longName":"EQ5D_CNSNT_EMP_RSN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3CAC5E0-3143-3446-E053-731AD00A2672","latestVersionIndicator":"Yes","beginDate":"2022-07-14","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-14","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeNote":"MA39/TL.","administrativeNotes":"11/16/23 Added alt OID for CCTG ticket number CADSR0003085 cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11475048","version":"1","preferredName":"Generalized Lost Productivity Questionnaire Other Specify Text","preferredDefinition":"The free-text field to specify other generalized lost productivity questionnaire text.","longName":"GN_LST_PRD_PROP_QUES","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB51B4F8-E526-2957-E053-731AD00A63CD","latestVersionIndicator":"Yes","beginDate":"2022-10-18","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-10-18","modifiedBy":"CLOHNES","dateModified":"2022-10-21","changeNote":null,"administrativeNotes":"10/18/22 created CDE for Chad Winch CCTG, added 6 alt OID, CCTG, added AQT cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12175285","version":"2","preferredName":"Remission status at transplantation time","preferredDefinition":"The status that describes the patient's remission status at the time of transplant.","longName":"SUPPPR_QVAL_REMSTAT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB4FAE6-8B88-28BF-E053-731AD00AF1AD","latestVersionIndicator":"Yes","beginDate":"2022-12-19","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-06-09","modifiedBy":"MMADDINENI","dateModified":"2023-06-09","changeNote":null,"administrativeNotes":"06/09/2023- Modified long name, created new version-MM, 12/19/2022- Created CDE-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12187535","version":"1","preferredName":"Stem Cell Transplant Type","preferredDefinition":"The type that indicates the Stem cell transplant type received.","longName":"PR_PRSCAT_SCT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F046FD14-50A6-5F79-E053-731AD00A5353","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-12-20","modifiedBy":"MMADDINENI","dateModified":"2023-01-06","changeNote":null,"administrativeNotes":"12/20/2022- created CDE-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12192441","version":"1","preferredName":"Conditioning Regimen Type","preferredDefinition":"The type that indicates the Conditioning Regimen type used prior to transplant.","longName":"SUPPPR_QVAL_CONDREG","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F04952D7-0CDF-4328-E053-731AD00A152C","latestVersionIndicator":"Yes","beginDate":"2022-12-20","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-12-20","modifiedBy":"MMADDINENI","dateModified":"2023-01-06","changeNote":null,"administrativeNotes":"12/20/2022- Created CDE-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12245404","version":"1","preferredName":"Patient Study Treatment Access Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"Indicator of whether or not patient has access to study treatment.","longName":"PT_ST_AC_CL_TR_EL_CR_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FC1F45-1B5C-6630-E053-731AD00ADB47","latestVersionIndicator":"Yes","beginDate":"2022-12-29","endDate":null,"createdBy":"CLOHNES","dateCreated":"2022-12-29","modifiedBy":"CLOHNES","dateModified":"2023-01-06","changeNote":null,"administrativeNotes":"12/29/22 Created CDE for CCTG for ticket number CADSR0001818 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12922567","version":"1","preferredName":"Treatment Protocol Actual Day Administered Number","preferredDefinition":"Reference to the actual day the treatment protocol was administered.","longName":"TR_PR_AC_DY_ADM_NUM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F561C7FB-F6C0-4E8F-E053-731AD00A0E18","latestVersionIndicator":"Yes","beginDate":"2023-02-23","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-02-23","modifiedBy":"CLOHNES","dateModified":"2023-02-27","changeNote":null,"administrativeNotes":"2/27/23 added alt name for CCTG ticket request CADSR0002081 and released CDE per Chad Winch cjl; 2/24/23 added AQT for CCTG ticket number CADSR0002081 cjl; 2/23/24 for CCTG ticket number CADSR0002081 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13168488","version":"1","preferredName":"Crossover Study Approval Indicator","preferredDefinition":"The indicator that describes whether or not a crossover study was approved.","longName":"CROVR_STUDY_APPR_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6CB8B23-F8FA-3FB5-E053-731AD00A78EB","latestVersionIndicator":"Yes","beginDate":"2023-03-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-03-13","modifiedBy":"CLOHNES","dateModified":"2023-03-14","changeNote":null,"administrativeNotes":"3/14/23 released per Chad Winch CCTG ticket number CADSR0002117 cjl; 3/13/23 Created CDE for CCTG ticket number CADSR0002117 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13336579","version":"1","preferredName":"Adverse Event Dose Modification Indicator","preferredDefinition":"Indicator or whether or not dose modification was due to an adverse event.","longName":"AE_DOSE_MOD_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE11F0-C6E7-50B6-E053-731AD00A14B4","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-04-10","modifiedBy":"CLOHNES","dateModified":"2023-06-16","changeNote":null,"administrativeNotes":"6/16/23 added alt OID and AQT for CCTG ticket number CADSR0002523 cjl; 4/10/23 created and released CDE to replace CDE 8083601 due to cleanup activities for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13374486","version":"1","preferredName":"Concomitant Medication Use Indicator","preferredDefinition":"A indicator whether the patient is taking any medication as outlined in the study protocol.","longName":"CM_CMYN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9A175C8-AA0F-55D6-E053-731AD00A74B1","latestVersionIndicator":"Yes","beginDate":"2023-04-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-18","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeNote":null,"administrativeNotes":"6/7/23 Released CDE for CCTG per quarterly metrics report cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13554544","version":"2","preferredName":"Covid-19 Protocol Deviation Type","preferredDefinition":"The type of protocol deviation occurred due to COVID-19.","longName":"DV_DVDECOD_COVID","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB3B110-8BC1-6990-E053-731AD00ABCC1","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-06-09","modifiedBy":"MMADDINENI","dateModified":"2023-06-09","changeNote":null,"administrativeNotes":"06/07/2023-Reviewed and released-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13554547","version":"2","preferredName":"Covid-19 Related Deviation Reason","preferredDefinition":"The reason for Covid-19 related protocol deviation.","longName":"DV_DVCAT_REAS_COVID","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB3ECF7-2872-74E3-E053-731AD00A4689","latestVersionIndicator":"Yes","beginDate":"2023-05-10","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-06-09","modifiedBy":"MMADDINENI","dateModified":"2023-06-09","changeNote":null,"administrativeNotes":"06/09/2023- Created new version-MM 06/07/2023-Reviewed and released-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13569524","version":"2","preferredName":"Covid-19 Test Specimen Type","preferredDefinition":"The type of biospecimen taken for COVID-19 testing.","longName":"MB_MBSPEC","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDA4A615-3B02-4535-E053-731AD00AB578","latestVersionIndicator":"Yes","beginDate":"2023-05-11","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-06-08","modifiedBy":"MMADDINENI","dateModified":"2023-06-09","changeNote":null,"administrativeNotes":"06/08/2023- Up versioned CDE, 06/07/2023-Reviewed and released-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13569893","version":"1","preferredName":"Covid-19 Positive Test Notification Public Health","preferredDefinition":"A Yes/No/Unknown/NA indicator that indicates if the COVID-19 positive test results are notified to public health.","longName":"SUPPMB_QVAL_NOTIFIND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB82A092-0387-4DB1-E053-731AD00A5A54","latestVersionIndicator":"Yes","beginDate":"2023-05-12","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-05-12","modifiedBy":"MMADDINENI","dateModified":"2023-06-07","changeNote":null,"administrativeNotes":"06/07/2023-Reviewed and released-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13594221","version":"1","preferredName":"Exposure as Collected Domain Dose Adjustment Modification Reason","preferredDefinition":"Text used to describe the reason why the dose was modified.","longName":"DS_MOD_REA","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FBFD83CD-5E04-0DEA-E053-731AD00AD1E7","latestVersionIndicator":"Yes","beginDate":"2023-05-18","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-05-18","modifiedBy":"CLOHNES","dateModified":"2023-06-16","changeNote":null,"administrativeNotes":"6/16/23 added alt name and AQT for CCTG ticket number CADSR0002523 cjl; 5/18/23 Created to replace CDE 8083670 per cleanup activities for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13682321","version":"1","preferredName":"Right Arm MIddle Point Between Antecubital Fossa And Axilla Measurement","preferredDefinition":"Numeric value to represent the middle point measurement of the right arm in between the antecubital fossa and the axilla.","longName":"RT_ARM_MID_PT_FOS_AXL_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC89B767-17B5-554E-E053-731AD00A4E80","latestVersionIndicator":"Yes","beginDate":"2023-05-25","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-05-25","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeNote":null,"administrativeNotes":"5/26/23 Created and released CDE to replace CDE 6080696 per cleanup activities for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13751001","version":"1","preferredName":"Right Arm Middle Point Between Antecubital Fossa And Wrist Joint Measurement","preferredDefinition":"Numeric value to represent the middle point measurement of the right arm in between the antecubital fossa and the wrist joint.","longName":"RT_ARM_MID_PT_FOS_WRS_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEB0BEE-1987-2E57-E053-731AD00A029A","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-05-30","modifiedBy":"CLOHNES","dateModified":"2023-05-31","changeNote":null,"administrativeNotes":"5/30/23 Created CDE to replace retired superceeded CDE 6080697 per cleanup activities for CCTG.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13751056","version":"1","preferredName":"Left Arm Middle Point Between Antecubital Fossa And Wrist Joint Measurement","preferredDefinition":"Numeric value to represent the middle point measurement of the left arm in between the antecubital fossa and the wrist joint.","longName":"LT_ARM_MID_PT_FOS_WRS_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEC01B1-3489-5AF3-E053-731AD00A85CE","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-05-30","modifiedBy":"CLOHNES","dateModified":"2023-05-31","changeNote":null,"administrativeNotes":"5/30/23 Created CDE to replace retired superceeded CDE 6080698 per cleanup activities for CCTG. Please use this CDE from now on cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13751666","version":"1","preferredName":"Left Arm Middle Point Between Antecubital Fossa And Axilla Measurement","preferredDefinition":"Numeric value to represent the middle point measurement of the left arm in between the antecubital fossa and the axilla.","longName":"LT_ARM_MID_PT_FOS_AXL_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCED9485-CF39-27C2-E053-731AD00A154E","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-05-30","modifiedBy":"CLOHNES","dateModified":"2023-06-01","changeNote":null,"administrativeNotes":"5/30/23 Created CDE to replace retired superceeded CDE 6080699 per cleanup activities for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13752186","version":"1","preferredName":"Right Arm Axilla Circumference Measurement","preferredDefinition":"Numeric value to represent the circumference measurement of the right arm axilla.","longName":"RT_ARM_AXL_CIRC_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEEE0D8-D149-6354-E053-731AD00A5A65","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-05-30","modifiedBy":"CLOHNES","dateModified":"2023-05-31","changeNote":null,"administrativeNotes":"5/30/23 Created CDE to replace retired superceeded CDE 6091413 per cleanup activities for the CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13774177","version":"1","preferredName":"Right Arm Middle Point Between Antecubital Fossa And Axilla Circumference Measurement","preferredDefinition":"Numeric value to represent the circumference measurement of the right arm at the middle point between the antecubital fossa and the axilla.","longName":"RT_ARM_MID_PT_FOS_AXL_CIR_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD11FA7B-90CA-3447-E053-731AD00A9C87","latestVersionIndicator":"Yes","beginDate":"2023-06-01","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-06-01","modifiedBy":"CLOHNES","dateModified":"2023-06-01","changeNote":null,"administrativeNotes":"6/1/23 Created CDE to replace retired superceded CDE 6091415 per cleanup activities for the CCTG. Please use this CDE from now on cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13787495","version":"1","preferredName":"Right Arm Antecubital Fossa Circumference Measurement","preferredDefinition":"Numeric value to represent the circumference measurement at the right arm antecubital fossa.","longName":"RT_ARM_FOS_CIRC_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD1691EF-A287-1A9D-E053-731AD00A4691","latestVersionIndicator":"Yes","beginDate":"2023-06-01","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-06-01","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeNote":null,"administrativeNotes":"6/1/23 Created CDE to replace retired superceded CDE 6091712 per cleanup activities for CCTG. Please use this CDE from now on cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13787498","version":"1","preferredName":"Right Arm Middle Point Between Antecubital Fossa And Wrist Joint Circumference Measurement","preferredDefinition":"Numeric value to represent the circumference measurement of the right arm at the middle point between the antecubital fossa and the wrist joint.","longName":"RT_ARM_MID_PT_FOS_WRS_CIR_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD1724A2-536D-55A3-E053-731AD00A377D","latestVersionIndicator":"Yes","beginDate":"2023-06-01","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-06-01","modifiedBy":"CLOHNES","dateModified":"2023-06-01","changeNote":null,"administrativeNotes":"6/1/23 Created CDE to replace CDE 6091929 per cleanup activities for CCTG. Please use this CDE from now on cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13792078","version":"1","preferredName":"Left Arm Axilla Circumference Measurement","preferredDefinition":"Numeric value to represent the circumference measurement at the left arm axilla.","longName":"LT_ARM_AXL_CIRC_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD275EB5-1E8C-3A22-E053-731AD00A04A9","latestVersionIndicator":"Yes","beginDate":"2023-06-02","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-06-02","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeNote":null,"administrativeNotes":"6/2/23 Created CDE to replace retired superceded CDE 6091933 per cleanup activities for CCTG. Use this CDE from now on cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13792080","version":"1","preferredName":"Left Arm Middle Point Between Antecubital Fossa And Axilla Circumference Measurement","preferredDefinition":"Numeric value to represent the circumference measurement of the left arm at the middle point between the antecubital fossa and the axilla.","longName":"LT_ARM_MID_PT_FOS_AXL_CIR_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD284F33-20BD-65E9-E053-731AD00A8A64","latestVersionIndicator":"Yes","beginDate":"2023-06-02","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-06-02","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeNote":null,"administrativeNotes":"6/2/23 Created CDE to replace CDE 6091935 due to cleanup activities for the CCTG. Please use this CDE from now on cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13795051","version":"1","preferredName":"Left Arm Antecubital Fossa Circumference Measurement","preferredDefinition":"Numeric value to represent the circumference measurement at the left arm antecubital fossa.","longName":"LT_ARM_FOS_CIRC_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD28C394-E008-790C-E053-731AD00AC53A","latestVersionIndicator":"Yes","beginDate":"2023-06-02","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-06-02","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeNote":null,"administrativeNotes":"6/2/23 Created CDE to replace CDE 6091937 per cleanup activities for CCTG. Please use this CDE from now on cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13795080","version":"1","preferredName":"Left Arm Middle Point Between Antecubital Fossa And Wrist Joint Circumference Measurement","preferredDefinition":"Numeric value to represent the circumference measurement of the left arm at the middle point between the antecubital fossa and the wrist joint.","longName":"LT_ARM_MID_PT_FOS_WRS_CIR_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD29B382-8634-2110-E053-731AD00AAAC2","latestVersionIndicator":"Yes","beginDate":"2023-06-02","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-06-02","modifiedBy":"CLOHNES","dateModified":"2023-06-02","changeNote":null,"administrativeNotes":"6/2/23 Created CDE to replace retired superceded CDE 6091944 per cleanup activities for CCTG. Please use this CDE from now on cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13798259","version":"1","preferredName":"Left Arm Wrist Joint Circumference Measurement","preferredDefinition":"Numeric value to represent the circumference measurement at the left arm wrist joint.","longName":"LT_ARM_WRS_CIRC_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD2A57DF-03DB-45B6-E053-731AD00A9DC0","latestVersionIndicator":"Yes","beginDate":"2023-06-02","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-06-02","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeNote":null,"administrativeNotes":"6/2/23 Created CDE to replace retired superceded CDE 6091946 per cleanup activities for CCTG. Please use this CDE from now on cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13798265","version":"1","preferredName":"Right Arm Wrist Joint Circumference Measurement","preferredDefinition":"Numeric value to represent the circumference measurement at the right arm wrist joint.","longName":"RT_ARM_WRS_CIRC_MEAS","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD2AFCA1-A1AD-5E3C-E053-731AD00A20E4","latestVersionIndicator":"Yes","beginDate":"2023-06-02","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-06-02","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeNote":null,"administrativeNotes":"6/2/23 Created CDE to replace retired superceded CDE 6092251 per cleanup activities for CCTG. Please use this CDE from now on cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14513733","version":"1","preferredName":"Patient Neoplasm Excision Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The response indicating whether or not the patient has a neoplasm for excision that meets the eligibility requirements for participation in a clinical trial.","longName":"PT_NEO_EXC_CT_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"067006AE-5B4F-4E77-E063-731AD00A4935","latestVersionIndicator":"Yes","beginDate":"2023-09-28","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-09-28","modifiedBy":"CLOHNES","dateModified":"2023-10-12","changeNote":null,"administrativeNotes":"10/12/23 Released CDE for CCTG ticket number CADSR0002884 cjl; 9/28/23 Created for CCTG ticket number CADSR0002884 and added alt OID, CCTG and AQT cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14596989","version":"1","preferredName":"Tumor Vascular Invasion Answer Indicator","preferredDefinition":"Indicator of whether or not there is tumor vascular invasion.","longName":"TUMOR_VASC_INV_ANS_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"097F4CC6-4043-4F37-E063-731AD00A95EA","latestVersionIndicator":"Yes","beginDate":"2023-11-06","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-06","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released CDE for CCTG cjl; 2023.11.8 Alt Sn added per ticket request CADSR0003053. ak 11/6/23 Created CDE for CCTG ticket number CADSR0003018 and AQT added cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14597091","version":"1","preferredName":"Form Booklet Number","preferredDefinition":"The form booklet number.","longName":"FORM_BKLT_NUM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09818F4D-8920-453E-E063-731AD00A30B9","latestVersionIndicator":"Yes","beginDate":"2023-11-06","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-06","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released CDE for CCTG; 11/06/23 Created CDE for CCTG ticket number CADSR0003034 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14598120","version":"1","preferredName":"How Much Does Bowel Function Affect Overall Quality of Life Score 4 Point Scale","preferredDefinition":"Person's stated response of how much their bowel function affects their overall quality of life, using a 4 point scale.","longName":"BWL_FNC_QOL_SCL","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09948648-FBDC-33FF-E063-731AD00A17DB","latestVersionIndicator":"Yes","beginDate":"2023-11-07","endDate":null,"createdBy":"TSESU","dateCreated":"2023-11-07","modifiedBy":"TSESU","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14598285","version":"1","preferredName":"Endoscopy Assessment Negation Administration Reason","preferredDefinition":"The reason an endoscopy was not administered.","longName":"ENDO_NOT_ADMIN_RSN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09AAC619-ECD7-4C09-E063-731AD00A8234","latestVersionIndicator":"Yes","beginDate":"2023-11-08","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-08","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released CDE for CCTG cjl; 11/08/23 Created CDE for CCTG ticket number CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14598286","version":"1","preferredName":"Digital Rectal Examination Assessment Indicator","preferredDefinition":"Indicator of whether or not a digital rectal examination was done.","longName":"DRE_ASSESS_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09AB6EAE-D3C6-699F-E063-731AD00AF542","latestVersionIndicator":"Yes","beginDate":"2023-11-08","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-08","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released CDE for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14598325","version":"1","preferredName":"Digital Rectal Examination Assessment Negation Administration Reason","preferredDefinition":"The reason a digital rectal examination was not done.","longName":"DRE_NOT_ADMIN_RSN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B907FC-93DD-2B07-E063-731AD00AAA37","latestVersionIndicator":"Yes","beginDate":"2023-11-09","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-09","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released CDE for CCTG cjl; 11/9/23 Created for CCTG ticket number CADSR0003018 AQT and alt OID added cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599125","version":"1","preferredName":"Second Restaging Completed Indicator","preferredDefinition":"Indicator of whether of not a second restaging was completed.","longName":"SCND_RESTAG_COMP_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09BC490E-1EBA-5CFD-E063-731AD00A866C","latestVersionIndicator":"Yes","beginDate":"2023-11-09","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-09","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released CDE for CCTG cjl; 11/09/23 Created CDE for CCTG ticket number CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599129","version":"1","preferredName":"Overall Tumor Clinical Response Type","preferredDefinition":"The type of overall tumor clinical response.","longName":"OVRALL_TMR_CLIN_RESP_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09BD1E88-3C1A-0F85-E063-731AD00AC61B","latestVersionIndicator":"Yes","beginDate":"2023-11-09","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-09","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl; 11/09/23 Created CDE and AQT and alt OID for CCTG ticket number CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599134","version":"1","preferredName":"Diffusion-Weighted Magnetic Resonance Imaging Performed Indicator","preferredDefinition":"Indicator of whether or not a diffusion-weighted MRI was performed.","longName":"DWI_PERF_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09BE5865-2034-47A5-E063-731AD00A3D1A","latestVersionIndicator":"Yes","beginDate":"2023-11-09","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-09","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl; 11/09/23 Created CDE and AQT and alt OID added for CCTG ticket number CADSR0003018","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599135","version":"1","preferredName":"Diffusion-Weighted Magnetic Resonance Imaging Performed Negation Administration Reason","preferredDefinition":"The reason a diffusion-weighted MRI was not done.","longName":"DWI_NOT_ADMIN_RSN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09BEE6A0-B08D-6D73-E063-731AD00AF63A","latestVersionIndicator":"Yes","beginDate":"2023-11-09","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-09","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599248","version":"1","preferredName":"Diffusion Weighted Imaging Performed Date","preferredDefinition":"Date that diffusion weighted imaging was performed.","longName":"DWI_PERF_DT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A098D3B-63B9-1285-E063-731AD00A68E1","latestVersionIndicator":"Yes","beginDate":"2023-11-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-13","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl; 11/29/23 Added alt OID for CCTG ticket number CADSR0003123 cjl; 1/13/23 Created CDE for CCTG ticket number CADSR0003018 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599254","version":"1","preferredName":"Patient Checklist Complete And Registration Eligibility Determination Indicator","preferredDefinition":"Indicator of whether or not the patient's checklist is completed and is eligible for registration.","longName":"PT_CHKLST_CMP_REG_ED_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A0A505F-9585-3CE4-E063-731AD00A5CAD","latestVersionIndicator":"Yes","beginDate":"2023-11-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-13","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl.;11/13/23 Created CDE for CCTG ticket number CADSR0003067 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599421","version":"1","preferredName":"Endoscopy Assessment Clinical Response Type","preferredDefinition":"The type of endoscopy assessment clinical response.","longName":"ENDO_ASSESS_CR_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A0BB3A8-6AE2-0E16-E063-731AD00A3512","latestVersionIndicator":"Yes","beginDate":"2023-11-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-13","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/13/23 Created CDE for CCTG ticket number CADSR0003018. Added AQT and alt OID cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599487","version":"1","preferredName":"Digital Rectal Examination Assessment Clinical Response Type","preferredDefinition":"The type of digital rectal examination assessment clinical response.","longName":"DRE_ASSESS_CR_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A0C4C47-0123-296D-E063-731AD00A6ECA","latestVersionIndicator":"Yes","beginDate":"2023-11-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-13","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/13/23 Created CDE for CCTG ticket number CADSR0003018. Added AQT and alt OID cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599488","version":"1","preferredName":"Diffusion Weighted Imaging Performed Clinical Response Type","preferredDefinition":"The type of diffusion weighted imaging clinical response type.","longName":"DWI_PERF_CR_TYPE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A0C938F-ECF4-3768-E063-731AD00AEFAE","latestVersionIndicator":"Yes","beginDate":"2023-11-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-13","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/13/23 Created CDE for CCTG ticket number CADSR0003018. Added alt OID and AQT cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599491","version":"1","preferredName":"T2-Weighted Magnetic Resonance Imaging Performed Indicator","preferredDefinition":"Indicator of whether or not a T2-weighted MRI was done.","longName":"T2W_MRI_PERF_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A0D0149-C2CB-55EB-E063-731AD00A6DAD","latestVersionIndicator":"Yes","beginDate":"2023-11-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-13","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/29/23 Added alt OID for CCTG ticket number CADSR0003123 cjl; 1/13/23 Created CDE for CCTG ticket number CADSR0003018. AQT added cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599499","version":"1","preferredName":"T2-Weighted Magnetic Resonance Imaging Performed Negation Administration Reason","preferredDefinition":"The reason a T2-Weighted MRI was not administered.","longName":"T2W_MRI_NOT_ADMIN_RSN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A0D24A3-EEF2-5B7D-E063-731AD00A956C","latestVersionIndicator":"Yes","beginDate":"2023-11-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-13","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/29/23 Added alt OID for CCTG ticket number CADSR0003123 cjl; 11/13/23 Created CDE for CCTG ticket number CADSR0003018 alt OID and AQT added cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599504","version":"1","preferredName":"T2-Weighted Magnetic Resonance Imaging Performed Date","preferredDefinition":"The date the T-2 weighted MRI was done.","longName":"T2W_MRI_PERF_DT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A0D5119-13DF-65F1-E063-731AD00AAF7D","latestVersionIndicator":"Yes","beginDate":"2023-11-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-13","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/29/23 Added alt OID for CCTG ticket number CADSR0003123 cjl; 1/13/23 Created CDE for CCTG ticket number CADSR0003018  Added AQT cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599505","version":"1","preferredName":"T2-Weighted Magnetic Resonance Imaging Performed Clinical Response Type","preferredDefinition":"The type of T2-Weighted MRI clinical response.","longName":"T2_MRI_PERF_CR_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A0D69E4-01CE-6969-E063-731AD00A78F7","latestVersionIndicator":"Yes","beginDate":"2023-11-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-13","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/29/23 Added alt OID for CCTG ticket number CADSR0003123 cjl;11/13/23 Created CDE for CCTG ticket number CADSR0003018. Added AQT cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599558","version":"1","preferredName":"Invasive Colorectal Carcinoma Tumor Cell Invasion Extent Depth of Tumor Invasion Type","preferredDefinition":"The depth of the tumor invasion of the colorectal carcinoma tumor cell.","longName":"INVS_CR_CA_TC_DEP_INV_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A1E840C-2F86-6176-E063-731AD00A2994","latestVersionIndicator":"Yes","beginDate":"2023-11-14","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-14","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/14/23 Created CDE for CCTG ticket number CADSR0003018 , added AQT and alt short name cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599621","version":"1","preferredName":"Total Mesorectal Excision Recommendation Indicator","preferredDefinition":"Indicator of whether or not a total mesorectal excision (TME) is recommended.","longName":"TME_REC_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A207B47-7FFC-454E-E063-731AD00A4753","latestVersionIndicator":"Yes","beginDate":"2023-11-14","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-14","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"11/10/23 Released for CCTG cjl;1/14/23 Created CDE for CCTG ticket number CADSR0003018 added alt OID and AQT cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599642","version":"1","preferredName":"Tumor Location Anal Anatomic Site","preferredDefinition":"The anatomic site location of the anal tumor.","longName":"TUM_LOC_ANL_ANAT_SITE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A210074-526B-6AE0-E063-731AD00AD259","latestVersionIndicator":"Yes","beginDate":"2023-11-14","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-14","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/14/23 Created CDE for CCTG ticket number CADSR0003018 added AQT and alt OID cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14599678","version":"1","preferredName":"Diffusion Weighted Imaging Performed Finding Result Status","preferredDefinition":"The term that describes the status of the diffusion weighted imaging finding result.","longName":"DWI_PERF_RES","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A22847F-327E-3BBC-E063-731AD00AC6EC","latestVersionIndicator":"Yes","beginDate":"2023-11-14","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-14","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/21/23 Added alt OID for CCTG ticket number CADSR0003101 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14604164","version":"1","preferredName":"Defect Closure Occurrence Indicator","preferredDefinition":"Indicator of whether or not there was a defect closure occurrence.","longName":"DEF_CL_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A361DCB-49F6-4E99-E063-731AD00ABBB0","latestVersionIndicator":"Yes","beginDate":"2023-11-15","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-15","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/15/23 Created CDE for CCTG ticket number CADSR0003018 added alt OID and AQT cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14604340","version":"1","preferredName":"Transanal Excision Surgical Platform Type","preferredDefinition":"The type of transanal excision surgical platform.","longName":"TES_PLTF_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A3736E0-5A75-0FE9-E063-731AD00A0AF1","latestVersionIndicator":"Yes","beginDate":"2023-11-15","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-15","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/15/23 Created CDE for CCTG ticket number CADSR0003018 added alt OID and AQT cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14607678","version":"1","preferredName":"Exposure as Collected Domain Exposure as Collected Intended Dose Milligram per Square Meter","preferredDefinition":"The intended dose in milligram per square meter to be administered.","longName":"EC_ECDSTXT_SCHEDULED","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A4CEC33-8ED5-1101-E063-731AD00AC490","latestVersionIndicator":"Yes","beginDate":"2023-11-16","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-11-16","modifiedBy":"MMADDINENI","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"11/21/23 Added 4 alt OIDs for CCTG ticket number CADSR0003101 cjl;11/16/2023-Created CDE (CADSR0003087)-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14607741","version":"1","preferredName":"Hip Prosthesis Indicator","preferredDefinition":"The indicator of whether or not there is a hip prosthesis.","longName":"HIP_PROST_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A5D78B4-D178-6970-E063-731AD00AE384","latestVersionIndicator":"Yes","beginDate":"2023-11-17","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-17","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/17/23 Created CDE for CCTG ticket number  CADSR0003085 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14607747","version":"1","preferredName":"Patient Interference Brachytherapy Implant Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The response indicating whether or not the patient has interference with having a brachytherapy implant placed that meets the eligibility requirements for participation in a clinical trial.","longName":"BT_IMPT_INTFR_CT_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A5DC305-151B-0325-E063-731AD00A1B97","latestVersionIndicator":"Yes","beginDate":"2023-11-17","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-17","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14607748","version":"1","preferredName":"Prostate Gland Actual Volume Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The response indicating whether or not the patient has the prostate gland volume that meets the eligibility requirements for participation in a clinical trial.","longName":"PV_EC_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A5E134D-89AC-144E-E063-731AD00A24F6","latestVersionIndicator":"Yes","beginDate":"2023-11-17","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-17","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/17/23 Created CDE for CCTG ticket number CADSR0003085, added alt OID and AQT cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14608590","version":"1","preferredName":"Total Number of Gleason 8-10 Cores Present Number","preferredDefinition":"The total number of Gleason 8-10 cores present.","longName":"GLSN_CORE_8_10_PRES_NUM","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A954795-0704-4BD6-E063-731AD00A3298","latestVersionIndicator":"Yes","beginDate":"2023-11-20","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-20","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/20/23 Created CDE for CCTG ticket number CADSR0003085, added alt OID and AQT cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14608593","version":"1","preferredName":"Cribriform Pattern Present Indicator","preferredDefinition":"The indicator of whether or not a cribriform pattern is present.","longName":"CP_PRES_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A95CE09-61F4-6300-E063-731AD00A8DBA","latestVersionIndicator":"Yes","beginDate":"2023-11-20","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-20","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14608855","version":"1","preferredName":"Prostate Specific Antigen Measurement Value Clinical Study Protocol Criterion Fulfill Indicator","preferredDefinition":"The response indicating whether or not the patient has a prostate specific antigen measurement value that meets the eligibility requirements for participation in a clinical trial.","longName":"PSA_MEAS_VAL_EC_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A98E3D4-A890-0E5F-E063-731AD00A82B7","latestVersionIndicator":"Yes","beginDate":"2023-11-20","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-20","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/20/23 Created CDE for CCTG ticket number CADSR0003085. Added alt OID and AQT cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14616460","version":"1","preferredName":"Person Correlative Study Specimen Submission And Collection Information Complete Indicator","preferredDefinition":"The indicator of whether or not the correlative study information related to specimen submission and collection was completed.","longName":"PERS_CS_INF_COMP_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0AAD7D13-C342-5967-E063-731AD00AEDBA","latestVersionIndicator":"Yes","beginDate":"2023-11-21","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-21","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;2023.12.5 Alt SN added per ticket request CADSR0003109. ak 2023.11.27 AQT added per ticket request CADSR0003109. ak 11/21/23 Created CDE for CCTG ticket number CADSR0003101 added AQT cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14621968","version":"1","preferredName":"Digital Rectal Examination Assessment Outcome","preferredDefinition":"Information related to the outcome of the digital rectal examination assessment.","longName":"DRE_ASSESS_RSLT","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B24F80C-7BD0-77AE-E063-731AD00A09D3","latestVersionIndicator":"Yes","beginDate":"2023-11-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-27","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;2023.12.5 Alt SN added per ticket request CADSR0003109. ak 2023.11.27 Created per ticket request CADSR0003109. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14634419","version":"1","preferredName":"Concomitant Medication Administered Reason","preferredDefinition":"The reason a concomitant medication was administered.","longName":"CM_ADM_RSN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6398ED-2774-18B9-E063-731AD00ADB4A","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/30/23 Created CDE for CCTG ticket number CADSR0003135 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14650190","version":"1","preferredName":"Procedure Domain Procedure Laterality Lymph Node Drainage Side Type","preferredDefinition":"The description of the laterality of the lymph node drainage side resulted by procedure.","longName":"PR_PRLAT_DRAINAGE","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0BF05F4B-7046-1EDC-E063-731AD00AD9BE","latestVersionIndicator":"Yes","beginDate":"2023-12-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-12-07","modifiedBy":"MMADDINENI","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"12/07/2023: Created CDE(CADSR0003150)-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14650261","version":"1","preferredName":"Procedures Supplemental Qualifiers Dataset Lymph Node Drainage Level Type","preferredDefinition":"The indication of lymph node drainage level.","longName":"SUPPPR_QVAL_DRAIN","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0BF20DA4-864A-788C-E063-731AD00A32D8","latestVersionIndicator":"Yes","beginDate":"2023-12-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-12-07","modifiedBy":"MMADDINENI","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"12/07/2023: Created CDE(CADSR0003150)-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14666970","version":"1","preferredName":"Laboratory Procedure Prostate-Specific Antigen Tumor Marker Result Response Indicator","preferredDefinition":"The response of the laboratory procedure prostate specific antigen tumor marker result.","longName":"PSA_TM_RSL_RESP_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D6C2E62-F594-622F-E063-731AD00ACE34","latestVersionIndicator":"Yes","beginDate":"2023-12-26","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-12-26","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;12/26/23 Created for CCTG ticket number CADSR0003208 , added AQT and alt OID cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14666971","version":"1","preferredName":"Salvage Therapy Administered Response Indicator","preferredDefinition":"Indicator of whether or not salvage therapy was administered.","longName":"SALVAGETX_ADM_RESP_IND","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D6C8E9F-54E9-7CC0-E063-731AD00A7AAE","latestVersionIndicator":"Yes","beginDate":"2023-12-26","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-12-26","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeNote":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;12/26/23 Created CDE for CCTG ticket number CADSR0003208, added AQT and alt OID cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14755429","version":"1","preferredName":"Disposition Domain Study Participant Consent Withdrawal Type","preferredDefinition":"A description of the type of consent withdrawal.","longName":"DS_WDC_TP","contextName":"CCTG","contextVersion":"1","dataElementConceptPublicId":"6004340","dataElementConceptVersion":"1","valueDomainPublicId":"3506068","valueDomainVersion":"1","origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"1145B026-321A-5940-E063-731AD00A0398","latestVersionIndicator":"Yes","beginDate":"2024-02-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2024-02-13","modifiedBy":"CLOHNES","dateModified":"2024-02-13","changeNote":null,"administrativeNotes":"2/13/24 Created CDE and added AQT for ticket number CADSR0003395 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"}]}